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The purpose of this study was to identify the differences in fall risk factors between 
diabetic and non-diabetic homebound adults in a population identified at high risk for falls.  The 
sample compared 210 non-diabetic homebound adults to 74 diabetic homebound adults.  Five 
research hypotheses supported this study. It was hypothesized that, 1) incidence and severity of 
somatosensory changes in the feet of diabetics surpassed that of non-diabetics; 2) incidence of 
lower leg and foot pain in diabetics surpassed that of non-diabetics; 3) deficits in sensory 
integration would be greater in diabetics than non-diabetics; 4) balance deficits were more 
evident in diabetics and non-diabetics; and 5) fear of falling was more prominent in diabetics than 
in  non-diabetics.  
 An one-way ANOVA showed a significant difference in sensation between groups, with 
diabetics reporting less sensation than non-diabetics in all age categories.  A small effect size 
limited external validity.  No other significant differences emerged for the other fall risk factors. 
Gender and age category failed to influence differences between diagnostic groups.  
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CHAPTER I 
 
INTRODUCTION 
 
 
The purpose of this study was to identify the differences in fall risk factors between 
diabetic and non-diabetic homebound adults.   Diabetes Mellitus is very common among older 
adults and has been identified as an important risk factor for falls in this growing older 
population, though the exact complications that lead to falling are not fully understood (McCoy, 
2003).  Diabetes as a risk factor for falls in general has been identified in urban community-
dwelling older adults, persons in rural communities, and in elderly nursing home residents with 
diabetes (Barr, Browning, Lord, Menz, and Kendig, 2005, Quandt, Stafford, and Bell, 2006, 
Volpato, Leveille, Blaum, Fried, and Guralnik, 2005).  Adults with diabetes may have a higher 
prevalence of neuropathy or impaired gait and balance, which can lead to an increased risk of 
falling (Schiller, Kramarow, and Dey, 2007).  One 3-year longitudinal study looked at 446 adults 
with diabetes and identified reduced peripheral nerve function, poor vision, weight loss, and poor 
renal function as predictors of falls (Barclay and Lei, 2008).  These researchers proposed that 
reducing diabetes-related complications may prevent falls (Schwartz, Vitinghoff, Sellmeyer, 
Feingold, De Rekeneire, and Strotmeyer 2008).  None of these studies included homebound older 
adults.   
A cohort of older adults missing from the geriatric research databases is the homebound 
elderly, including the homebound diabetic older adult.  The Centers for Medicare and Medicaid 
(CMS) define “homebound” as the inability to leave home without considerable and taxing effort.  
A person may leave home for medical treatment or short, infrequent absences for non-medical 
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reasons, such as a trip to attend religious services (CMS, 2003). Conducting clinical research is 
difficult with this population that may fear medical establishment, have trouble following 
complicated procedures, lack transportation, or want to avoid lengthy forms (Ritchie and Dennis, 
1999), though evidence points to the disproportionate share of morbidity and disability in this 
group (Ganguli, Fox, and Gilby, 1996).  Older adults who meet this definition would find it very 
difficult to participate in traditional medical research studies based in laboratories, medical 
centers, or doctor’s offices.  Unfortunately, these homebound elderly are in need of more 
intensive healthcare and are associated with poor social support, poor self-rated general health, 
weight loss, stroke, angina, arthritis of the spine, and falls (Ganguli et al, 1996). 
Falls are associated with several negative health consequences. Falls can be markers of 
poor health and declining function, and they are often associated with significant morbidity 
(Fuller, 2000). Compared with children, elderly persons who fall are 10 times more likely to be 
hospitalized and eight times more likely to die as the result of a fall (Runge, 1993).  Falls are the 
leading cause of injury-related visits to emergency departments in the United States and the 
primary etiology of accidental deaths in persons over the age of 65 years (Burt and Fingerhut, 
1998, Centers for Disease Control [CDC], fatal falls, 2003).  The mortality rate for falls increases 
dramatically with age in both sexes and in all racial and ethnic groups, with falls accounting for 
70 percent of accidental deaths in persons 75 years of age and older (Tibbits, 1996). More than 90 
percent of hip fractures occur as a result of falls, with most of these fractures occurring in persons 
over 70 years of age (Greenhouse, 1994).  More than 325,000 hip fractures occur each year in the 
United States, a figure that is predicted to grow to 650,000 per year by 2040 (Kozak, Hall, and 
Owings, 2002).   In 2005, a total of 15,802 persons 65 years of age or older died as a result of 
injuries from falls (Stevens, Mack, and Paulozzi, 2008). One third of community-dwelling elderly 
persons and 60 percent of nursing home residents fall each year (Adams, Day, and Vickerie, 
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2007). Risk factors for falls in the elderly include increasing age, medication use, cognitive 
impairment and sensory deficits (Fuller, 2000).  The growing elderly population, incidence of 
diabetes, and consequences of falls support investigation of fall risk factors in elderly with and 
without diabetes, especially for those homebound elderly who need more answers from 
traditional medical research. This information can help identify prevention strategies for older 
adults who may be at higher risks for fall injuries, such as homebound elderly and diabetic older 
adults. 
Based on previous research and clinical data, it was hypothesized that diabetic 
homebound adults will demonstrate poorer scores on multiple measures of fall risk factors that 
impact the ability to safely maintain postural control than do non-diabetic homebound adults, 
including impaired somatosensation in the feet, increased lower extremity and foot pain,  
decreased sensory integration, decreased balance, and fear of falling.  It was expected that these 
differences will exist between diabetic and non-diabetic homebound adults due to the multiple 
complications that result from diabetes, even when both cohorts are identified as having an 
increased risk for falls.  It was hypothesized that these diabetic complications will negatively 
impact all five fall risk factors, distinguishing the diabetic cohort from the non-diabetic 
homebound older adult.        
Research Hypotheses 
This study tested five research hypotheses.  It was hypothesized that: 1)the incidence and 
severity of somatosensatory loss in the feet, as measured by Semmes-Weinstein monofilaments, 
are significantly different between homebound Type 2 diabetic adults and non-diabetic 
homebound adults, 47 years of age and older;  2) the incidence of lower leg and foot pain as 
measured by a verbal rating scale (VRS) specific to neuropathic foot and leg pain is greater in 
diabetic homebound adults than non-diabetic homebound adults; 3)deficits in sensory integration 
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as measured by the modified Clinical Test for Sensory Integration and Balance (m-CTSIB) are 
greater in homebound diabetic adults than in non-diabetic homebound adults; 4) balance, as 
measured by the Dynamic Gait Index, is significantly different between homebound Type 2 
diabetic adults and non-diabetic homebound adults; and 5)fear of falling as measured by the 
Modified Falls Efficacy Scale (MFES) is greater in homebound diabetic adults than in 
homebound non-diabetic adults.  
In conclusion, many studies have documented increased fall risk in the diabetic 
population, but few of them assessed differences between fall risk factors in non-diabetic and 
diabetic homebound elderly.  Understanding the differences between homebound diabetic and 
non-diabetic populations can potentially improve quality of life through earlier screenings for fall 
risk, more complete diabetic education, and effective healthcare that targets appropriate deficits. 
Hypothesis I 
It was hypothesized that the incidence and severity of somatosensory changes in the feet, 
as measured by Semmes-Weinstein monofilaments, are significantly different between 
homebound Type 2 diabetic adults and non-diabetic homebound adults, 47 years of age and older, 
because there is a higher incidence of sensory loss in the diabetic population.  Approximately one 
half of people with diabetes have some form of peripheral neuropathy (Dyck, Kratz, and Karnes, 
1993) with 40% of the estimated 20.8 million US diabetic adults experiencing loss of foot 
sensation during their lifetimes (Narayan,, Boyle, and Geiss, 2006).   
Hypothesis II 
It was hypothesized that incidence of lower leg and foot pain as measured by a verbal 
rating scale (VRS) is greater in diabetic homebound adults, 47 years of age and older, than non-
diabetic homebound adults because diabetics have a higher incidence of neuropathic pain than do 
non-diabetic adults. The prevalence of these somatosensory changes that result in painful diabetic 
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peripheral neuropathy is estimated at 26.4 % for Type II diabetes (Davies, Brophy, Williams, and 
Taylor, 2006).  Others estimate the incidence of neuropathic pain from 11% to 32% in diabetics 
with polyneuropathy (Slyke, 2000, Vinik, Park, Stansberry, and Pitteneger, 2000).      
Hypothesis III 
It was hypothesized that deficits in sensory integration as measured by the modified 
Clinical Test for Sensory Integration and Balance (m-CTSIB) is greater in homebound diabetic 
adults, 47 years of age and older, than in non-diabetic homebound adults because diabetics are 
characterized by having a higher incidence of visual and somatosensory changes than non-
diabetics adults which could negatively impact sensory integration.  Diabetic retinopathy (DR) is 
a complication that can affect the peripheral retina, the macula, or both and is the leading cause of 
visual disability and blindness in diabetics (World Health Organization, 2007).  The prevalence of 
DR increases with prolonged duration of the disease; most people with diabetes over 30 years 
have some form of DR (Kempen, Colmain, and Leske, 2004).  This loss of normal vision, 
coupled with the previously described somatosensory loss, will have a negative impact on sensory 
integration related to balance.      
Hypothesis IV 
 It was hypothesized that balance, as measured by the Dynamic Gait Index, is significantly 
different between homebound Type 2 diabetic adults, 47 years of age and older, and non-diabetic 
homebound adults because diabetics in general have a higher incidence of falling due to impaired 
balance. Uccioli and colleagues found a direct correlation between presence of peripheral 
neuropathy and postural instability (Uccioli, Giacomini, and Pasqualetti, 1997).  Since diabetics 
experience an increased prevalence of peripheral neuropathy, they could also experience an 
increased incidence of postural instability or poor balance.       
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Hypothesis V 
It was hypothesized that fear of falling as measured by the Modified Falls Efficacy Scale 
(MFES) is more significant in homebound diabetic adults, 47 years of age and older, than in 
homebound non-diabetic adults because the higher incidence of falls in diabetics is associated 
with an increase in fear of falling. An estimated one third of adults who fall develop a fear of 
falling (Vellas, Wayne, and Romero, 1997) and because adults with diabetes have an increased 
risk of falling (Schiller, 2007), they could experience more fear of falling than non-diabetic older 
adults.   
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
Incidence and Prevalence of Diabetes 
Type 2 diabetes mellitus, also known as adult-onset diabetes or non-insulin dependent 
diabetes mellitus (NIDDM), is a major, global health problem that affects over 124 million 
individuals worldwide (American Diabetes Association [ADA], 2002).  In the United States, 
Type 2 diabetes accounts for 90% of the 15.7 million Americans who are suffering from diabetes 
(Quinn, 2001).  The true number of Americans with diabetes may be closer to 17 million because 
of the large number of people who meet current criteria for diabetes and do not know they have 
the disease (Halter, 2002).   Marked increases in incidence have been noted in children, 
adolescents, and young males in their 30s (Quinn, 2001, McDougall, 2001).  The public may be 
aware of the more severe consequences of long-term diabetes, such as impotence, blindness, heart 
attack, stroke, amputation, or death.  What individuals may not be aware of are the subtle early 
warning signs of the onset of this condition because they can mimic typical signs of age-related 
physical decline.  These signs can include mild numbness in the hands or feet, unusual thirst, loss 
of weight, or difficulty with wound healing (Goodman and Boissonnault, 1998).  These signs may 
not be recognized as diabetic symptoms and can go untreated for years.  This lack of education 
regarding diabetes contributes to the high incidence of non-diagnosis and to the loss of 
opportunity to prevent disability and decrease mortality rates associated with this disease.  Newly 
diagnosed diabetics may actually exhibit disease-related declines resulting from years of diabetic 
pathology because they did not recognize the subtle, progressive changes in physical function.   
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The incidence of Type 2 diabetes in America has dramatically increased over the past 50 
years, from fewer than 2 million cases in 1958 to an estimate of 17 million cases today (Halter, 
2002).  The incidence increases with age and the percentage of adults with diabetes rises to over 
50 percent for those 75 years and older (CDC [diabetes statistics], 1999).  The long-term 
complications of diabetes in elderly people can be devastating to functional independence and 
include coronary heart disease, stroke, and amputation (Halter, 2002).  The consequences of this 
epidemic disease demand attention from health care providers and researchers in order to find 
more effective methods of detection, intervention, and cure. 
 The incidence of diabetes in homebound older adults is difficult to determine, but several 
federal databases attempt to track and record this information.  The US Department of Health and 
Human Services compiled a report on Trends in Health and Aging (CDC [national fact sheet], 
2004) that lists diabetes as the fourth most common morbidity in adults aver the age of 65, behind 
hypertension, arthritis, and heart disease.  North Carolina has the fifth highest incidence of 
diabetes with a total of 19.8 % of the population with this disease between the 2002-2004 period 
(CDC [health statistics], 2004). 
Approximately 16 million households in the United States contain a householder 60 years 
of age or older, but how many of them are homebound is unknown (Administration on Aging, 
2000).  The Center for Medicare Services does report that 3% of the US healthcare expenditures 
is spent on homecare (CMS, 2002).  In one study in rural Pennsylvania, 10.3 % of their sample 
was classified as homebound, which was associated with being female, older, widowed, with 
poorer cognitive and functional impairment, more depressive symptoms, poorer social support, 
fair to poor self-rated general health, weight loss, and histories of stroke, angina, arthritis of the 
spine, and falls (Ganguli et al, 1996).  As our population ages and health care costs increase, it is 
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imperative to understand the impact of diabetes on what is considered as the most vulnerable 
subgroup of elders for functional decline, homebound elders (Sharkey and Branch, 2004).           
Diabetes was reported as one of the leading causes of death in the US among persons 
aged 65 or older during the period from 1980 to 1997 (CDC [National Center for Health 
Statistics], 1997).  In 2002, diabetes was the sixth leading cause of death in the United States, 
doubling the risk of death for diabetics compared to non-diabetics (CDC [diabetes], 2005).  An 
issue that results in both financial and emotional strain is the degree of disability resulting directly 
or indirectly from this serious condition.  A significant degree of disability, or the inability to 
perform necessary daily activities, can prevent older adults from fulfilling social roles, engaging 
in healthy interactions with friends and family, and maintaining a strong sense of self-hood 
(Marshall, 1996).  As the incidence of chronic conditions increases with age, as is the case with 
DM, older adults may also suffer from negative changes in stress management, coping skills, 
mental health, and emotional support networks (George, 1996).  If chronic diabetes can accelerate 
the aging process and speed the onset of disability, then researchers are compelled to identify 
interventions that can prevent or slow the onset of these negative consequences.   
Etiology, Signs, and Symptoms  
Diabetes mellitus is a disease involving the body’s inability to produce or properly use 
insulin.  This hormone is needed for the conversion of sugar and starches into energy.  Insulin is 
also crucial for maintaining safe glucose levels in the blood stream because of the role in 
promoting glucose entry into the cells.  Environmental factors and genetics (Goodman and 
Boissonnault, 1998) are thought to play a role in the etiology of this disease, but the full 
explanation for the cause of DM is unknown.  Obesity has been identified as a continuous risk 
factor for diabetes onset (Hillier and Pedula, 2001).  One study reported an inverse relationship 
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between socioeconomic status and prevalence of Type 2 DM in the middle years of life (40-69 
years) (Connolly, Unwin, and Sherriff, 2000). 
Classification 
Two major types of DM have been identified.  Type 1 diabetes is defined as an 
autoimmune disease in which the body does not produce insulin secondary to the destruction of 
insulin-producing beta cells in the pancreas. This type of DM occurs more often in children and 
young adults and accounts for 5-10 % of all diabetes cases (ADA , 2002).  Type 2 DM is the most 
common form of the disease and is classified as a metabolic disorder resulting from the lack of, or 
dysfunction in the use of, insulin. The prevalence of this disease in older Americans rises as 
obesity and sedentary lifestyle increases.  Risk factors for Type 2 diabetes include being over 45 
years of age, having a family history of DM, being overweight, lack of regular exercise, high 
triglycerides or low HDL cholesterol, women who had gestational diabetes, or being a member of 
certain ethnic groups (African Americans, Latinos, Asian and Pacific Islanders, and Native 
Americans)(ADA, 2002).  Often people with Type 2 diabetes have no symptoms or may ignore 
the early warning signs for either Type 1 or Type 2 diabetes.  Common symptoms for Type 1 
disease include frequent urination, unusual thirst, extreme hunger, unusual weight loss, extreme 
fatigue, and irritability.  Signs for Type 2 diabetes include any of the Type 1 symptoms and may 
also involve blurred vision, slow healing wounds, tingling or numbness in the hands or feet, and 
recurring skin, gum or bladder infections.   
The American Diabetes Association describes a period of pre-diabetes prior to the 
development of Type 2 DM, during which individuals can adopt lifestyle changes in order to 
prevent or delay onset of this disease (ADA, 2002).  They define pre-diabetes as a period during 
which blood glucose levels are higher than normal but not yet high enough to be diagnosed as 
diabetes.   The ADA reports that recent research has shown that some long-term damage to the 
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body, especially to the heart and circulatory system, may already be occurring during the pre-
diabetes period.   Studies have shown clear benefit of glucose lowering in pre-diabetics to prevent 
or retard the progression of microvascular complications (UK Prospective Diabetes Study, 1998, 
Ohkubo, Kishikwa, and Araki, 1995, Reichard, Nilsson, and Rosenqvist, 1993), and that 
microvascular disease is already present in many individuals with undiagnosed or newly 
diagnosed Type 2 diabetes (Tuomilehto, Lindstom, and Eriksson, 2001, The Diabetes Prevention 
Research Group, 1999 & 2000).  
Diagnosing Diabetes 
The diagnosis of diabetes mellitus must be made by a physician. A diagnosis of diabetes 
is based on blood glucose levels, which can be measured by two different tests.  The fasting 
plasma glucose test (FPG) defines pre-diabetes as a level between 110 and 125 mg/dl.  The oral 
glucose tolerance test (OGTT) defines this pre-clinical period as a level between 140 and 199 
mg/dl. (ADA, 2000).  The FPG is used more often for diagnosis because it is less complicated, 
but can lead to under-diagnosis in older adults (Halter, 2002).  For the FPG scale, a reading of 
less than 110 mg/dL is considered normal, 110-125 mg/dL is the impaired range, and a reading of 
more than 125 mg/dL is classified as diabetes.  The American Diabetes Association recommends 
that the FPG show elevated plasma glucose twice before establishing a diagnosis for diabetes 
(Halter, 2002).  For the OGTT, a reading less than 140 mg/dL is considered normal, 140-199 
mg/dL is in the impaired range, and over 200 mg/dL is classified as diabetes.  The current 
standard of practice is the FPG screening using the ADA ranges listed (Halter, 2002).   
 Most diabetics do not recognize the early warning signs of this disease and may go 
undiagnosed for an extended period of time.  The CDC reports as many as 7 million adults with 
undiagnosed diabetes (CDC, 2004).  Duration of the disease is one of the most prominent factors 
in degree and severity of neuropathy, so accurately determining onset is very important to 
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understanding and staging nervous system changes.   Some studies have defined newly diagnosed 
as 2 months post-physician diagnosis, with follow-up at 12, 24, and 36 months of study.  Other 
investigators set the definition of “newly diagnosed” from one-day post-diagnosis to one-year 
post-diagnosis.  Recently diagnosed diabetic adults was defined as 3-4 years of duration in one 
study (Bornmyr, Castenfors, and Svensson, 1999), but this does not appear to be a conservative 
approach as many adults may go undiagnosed for up to 10 years (Harris, Hadden, Knowler, and 
Bennett, 1987).  A national health survey in 2005 estimated that almost 30% of all diabetes cases 
were undiagnosed by physicians (National Center for Health Statistics, Centers for Disease 
Control [NHANES], 2005).   Adult diabetics who have been diagnosed for 1-5 years are 
generally categorized as having the illness for a short duration, 6-10 years as a moderate duration, 
and over 10 years as a long duration (Koltringer, Langsteger, Lind, Klima, Wakonig, and 
Reisecker, 1992, Toyry, Partanen, Niskanen, Lansimies, and Uusitupa, 1997).     
Normal Aging and Diabetes  
         Older adult diabetics who miss the opportunity for prevention of this condition must deal 
with the normal changes associated with aging as well as the devastating symptoms associated 
with diabetes.  The “normal” physical changes associated with aging may include loss of 
flexibility and muscle strength, decreased endurance, impaired balance and postural control, 
impaired fluid intelligence (abstract reasoning), sensory deficits, and the resulting decreased 
functional mobility and independence (Spirduso, 1995).  Several changes in cognition with aging 
that are well documented include cognitive slowing, decreases in working memory, decreases in 
overall cognitive resource capacity, and poorer long-term memory function (Park, 2000).  Making 
a bleak picture even more disappointing is the multitude of other factors that influence cognitive 
performance of the elderly population.  Education, income and race were significant predictors of 
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cognitive performance in a cohort of 1,192 community-dwelling elders (Inouye, Albert, and 
Mohs, 1993).  
Other typical physical consequences of growing older can include presbyopia (normal 
changes in vision due to aging), presbycusis (hearing loss), weakened immune system, and a 
varying degree of memory impairment (Roush, 1999).  The endocrine system also changes with 
age and may lead to changes in the production and secretion of several hormones, including 
insulin (Wise, 1999).  These declines in physical health do not have to be absolute, despite the 
common opinion that they are inevitable.  The myths about declines with advanced age include 
loss of functional muscle strength, poor cardiac function, little to no desire for an active sex life, 
and dementia (Spirduso, 1995). 
Another clear finding related to aging and physical change is that disuse accelerates 
aging-related changes and pathology and can diminish physiologic reserves (Timiras, 1994).    
Muscle strength declines with age are attributed largely to a loss of muscle mass resulting from a 
loss of muscle fibers.  The muscle wasting associated with aging is referred to as sarcopenia and 
is present in 6% to 15% of older adults (Cech & Martin, 2002).  Other mechanisms also are 
thought to be involved in muscle wasting because older individuals who undergo strength training 
have increases in strength that are greater than their increases in muscle mass (Fiatarone, 1994).  
Strength training may also have beneficial effects on the neurons that innervate the active muscles 
because neural fibers atrophy when their target muscle is not used.  Other physical changes that 
accompany advancing age are increase in body fat and decrease in bone density (Pahor and 
Kritchevsky, 1998).  Inactivity contributes to both of these changes that can result in decreased 
function and quality of life (Gersten, 1991).  
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Aging Confounded by Diabetes 
 The consequences of diabetes mellitus can mimic “typical” signs of age-related declines 
in health.  Clinical manifestations of diabetes usually include the cardinal signs of polyuria 
(excessive urination), polydipsia (excessive thirst), polyphagia (excessive hunger), weight loss, 
and fatigue (Goodman and Boissonnault, 1998).  A common complaint of older adults may be 
more frequent trips to the bathroom at night and changes in appetite or eating habits.  The 
normally aging population may not recognize changes in thirst or hunger or frequent urination as 
abnormal for their age.  Some older adults may also consider weight loss and fatigue as typical 
changes with aging and not as potential warning signs for diabetes.  Symptoms more easily 
identifiable as diabetes-related are visual blurring, neuropathic complications such as foot pain, or 
infections (Goodman and Boissonnault, 1998).  Type 2 diabetes is commonly diagnosed while the 
person is hospitalized or receiving medical care for another problem associated with DM 
(neuropathy, retinopathy, or nephropathy).  Because normal aging and the clinical course of DM 
share many physical complications, diabetes can go undetected for months or years, resulting in 
more severe long-term consequences. 
Other declines associated with aging are also potentially related to the diabetic disease 
process.  Cardiorespiratory function and endurance decrease with aging in the average older adult 
(Spirduso, 1995).  Factors such as maximum heart rate, cardiac output, and oxygen consumption 
decline with age (Spirduso, 1995).  Other changes are also observed with aging.  These include a 
decline in maximal exercise capacity and maximum heart rate, an increase in systolic blood 
pressure and left ventricle wall thickness, and deterioration in glucose and lipid metabolism, 
which can be accelerated by diabetes.  Some cardiac measures change very little with age, 
including heart size, end-systolic volume, and volume of blood ejected at rest (Spirduso, 1995).    
One very important physiologic measure, that of systolic and diastolic blood pressure, increases 
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with age, due primarily to a thickening and hardening of the aorta and arterial tree and to an 
increase in peripheral resistance.  This increased blood pressure is also a common problem with 
diabetes and is a risk factor for more serious cardiac dysfunction such as stroke, postural 
hypotension, or aneurysm.  In contrast to cardiac changes, in general, healthy older adults have 
pulmonary systems that function very well under resting and moderate exercise conditions.  If 
older adults are sedentary, the maximum amount of oxygen they can consume during work 
declines about 10% each decade.  
Changes in cognition are another commonality of aging and diabetes.  High blood 
pressure is associated with cognitive impairment in healthy, drug-free older adults, as well as 
being a major risk factor for multi-infarct dementia (Starr, Whalley, and Inch, 1993).  High blood 
pressure and diabetes coexist in 60-65% of diabetic adults (Contreras, River, and Vasques, 2000) 
magnifying the risk for poorer cognitive performance in diabetic adults, which may impact speed 
of decision-making especially in physically challenging situations. Both diabetes and 
hypertension share the same predisposing factors and increase in frequency with age.  This may 
lead to an increased risk for falls for cognitively impaired older adults with diabetes. 
 Controlling the onset of unfavorable long-term consequences requires early diagnosis and 
treatment for three major metabolic problems associated with diabetes: 1) decreased utilization of 
glucose, 2) increased fat mobilization, and 3) impaired protein utilization (Goodman and 
Boissonnault, 1998).  If untreated long-term complications of diabetes may include microvascular 
problems resulting in retinopathy (retinal disease), nephropathy (kidney disease), and peripheral 
(motor and sensory) and autonomic neuropathy (nerve disease).  Atherosclerosis begins earlier 
and is more extensive in this population and can result in skin and nail changes, poor tissue 
perfusion, decreased or absent pedal pulses, and impaired wound healing.  Hyperglycemia 
impairs resistance to infection so skin and urinary infections may occur.  The loss of normal 
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sensation in diabetic neuropathy predisposes joints to repeated trauma and progressive joint 
destruction.  Sensory neuropathies may cause tingling, burning, numbness, or complete loss of 
feeling in hands and feet.  This lack of protective sensation contributes to the cycle of repeated 
trauma, potential infection, lack of healing, more trauma, and more infection.  Motor neuropathies 
produce muscle weakness and joint deformity, such as claw toes or flat feet.  Autonomic 
neuropathy may result in loss of sweating regulation, temperature control, and blood flow in the 
limbs.  
  Understanding the microvascular changes that result from diabetes is critical for 
understanding the accelerated aging process and clinical picture of diabetics.  One method for 
studying the link between vascular health and diabetic course involves examining the 
vasoconstrictor response in normal adults as compared to diabetic adults.  To do this, skin blood 
flow response to deep inspiration has been studied using laser Doppler flowmetry (Smith, 
Thomas, and Torgersen, 1994).  Laser Doppler flowmetry is an innovative technique used to 
measure the erythrocyte (red blood cell) volume and velocity in the upper horizontal plexus of the 
skin via a noninvasive laser signal.  Terminal arterioles, capillaries, and postcapillary venules are 
monitored to obtain flow in units of milliliters per minute per 100 gram of tissue.    Deep 
inspiration is known to cause an abrupt reduction in skin blood flow in the extremities by 
inducing vasoconstriction.  This activity tests the peripheral sympathetic function that controls 
blood flow to the extremities.  In healthy adults a deep inspiration causes an abrupt reduction in 
skin blood flow response with a latency of a few seconds.  This transient decrease in skin blood 
flow is impaired or absent in adults with moderate to severe diabetic autonomic neuropathy 
(Yoshimasa, Toshihiko, and Yoshihiro, 1997). Postural hypotension has also been measured in 
diabetic patients and is a clinical hallmark of advanced diabetic autonomic neuropathy, as well as 
being a somewhat common occurrence with advanced age.  Lack of vasoconstriction is thought to 
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be the primary cause of diabetic postural hypotension.  These vasomotor responses in diabetic 
adults appear to be completely abolished in DM adults with foot ulceration and poor wound 
healing (Cacciatori, Dellera, and Bellavere, 1997). 
 Answers to why and how vascular dysfunction impacts adults with diabetes are still 
forthcoming.  One potential explanation centers on peripheral nerve function.  Poor nerve 
function in the extremities can be shown to impact control of vasoconstriction and has been 
linked to increased age, glycemic control, and diabetic duration.  Determining which dysfunction 
develops first, either poor nerve function or vascular dysfunction, is hard to predict, but some 
researchers suggest that the vascular factors participate in the development of the nerve lesions 
(Valensi, Girous, and Seeboth-Ghalayni, 1997).  Glycemic control seems to be an important risk 
factor in the deterioration of nerve function in Type 2 DM.  Most diabetic adults have poor 
glycemic control and disturbed nerve function at the time of diagnosis (Lehtinen, Nishanen, and 
Hyvonen, 1993).  A promising result from one study demonstrated that restoring lower extremity 
blood flow improved nerve conduction velocity (an indicator of nerve function) in diabetics 
presumably due to an increase in tissue oxygenation (Young, Veves, and Smith, 1995).  Risk 
factors for microvascular complications involving nerve function include hyperglycemia, age, 
tobacco use, dyslipidemia, hypertension, duration of diabetes, and microalbuminuria (Cade, 
2008).  Without intervention peripheral nerves will begin to show axonal thickening and eventual 
axonal loss, basement membrane thickening, loss of microfilaments that form actin and myosin, 
and decreased capillary blood flow to C fibers that carry pain signals (Cade, 2008).  Improvement 
in microvascular blood flow, control of glycemia, and control of blood pressure present areas in 
need of research in order to find interventions that can impact the onset of diabetic symptoms.    
 An example of these investigations is work focusing on cutaneous microvascular flow in 
the hands and feet using laser Doppler flowmetry.  Comparisons have been made between control 
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and diabetic subjects using this technique to study the normal age-related decline in 
microvascular function in the extremities and the resulting pattern of blood flow.   Results of one 
study using deep inspiration as the stimulus indicate that diabetic adults do not have a typical 
negative slope, or decline, in microvascular function, as do normal adults because the diabetic 
subjects started with a lower baseline and display blunted responses to stimuli.  Younger diabetic 
subjects display a blood flow pattern similar to that seen in the advanced aging process. 
(Stansberry, Hill, Bril, Kojic, and Ngo, 1997).  The abnormal vascular reactivity displayed in 
these adults was described as either a decreased vascular response to stimuli or loss of autonomic 
nerve supply.  It is unclear whether this loss of autonomic nerve function occurs at the local, 
reflex, or centrally mediated level for microvasculature reactivity.  Stansberry also found 
diminished amplitude and frequency of the normal spontaneous vasomotion resulting from 
rhythmic vasoconstriction of the arterioles.  Potential mechanisms for these changes were 
decreased arteriolar wall reactivity and stiffening of the vessel walls due to an excessive 
accumulation of proteins as a result of advanced glycosylation (Stansberry, 1996).  The process of 
glycosylation is also associated with accelerated aging.  In addition, aging has been linked to a 
loss of superficial nutritional dermal capillaries (in the skin) that mimics the altered sympathetic 
regulation of pre-capillary sphincter tone in the vessel walls of diabetic adults.  Stansberry also 
proposed that decreased vasomotor amplitude correlates with the loss of thinly myelinated C-fiber 
function, which is the type of nerve fiber that carries afferent pain and temperature information 
(Stansberry, 1996).  
Diabetic peripheral neuropathy can be manifested as loss of lower extremity sensation 
and is one of the common negative consequences of diabetes.  Sensory loss places diabetic adults 
at risk for falls, foot ulcers, and amputation. (Mayfield and Sugarman, 2000, Conner-Kerr and 
Templeton, 2002, Richardson and Hurvitz, 1995, Armstrong, Laverly, and Harkless, 1998). 
19 
 
Diabetic neuropathy begins with symmetrical nerve damage and motor loss in the feet, with pain 
and eventual insensitivity beginning in the toes and continuing proximally (Elftman, 1992).  
Typically, sensory involvement begins in the lower extremities before the upper extremities.   
Sensory testing of the hands is indicated once the pattern of sensory loss extends up the calf 
(Abbott, Carrington, and Ashe, 2002, Olaleye, Perkins, and Bril, 2001). The diabetic neuropathy 
process can begin regardless of the person’s history of disease control, although poor compliance 
with prescribed treatment results in more severe complications (Elftman, 1992).     
Older adults who suffer from Type 2 diabetes must deal with the normal changes 
associated with aging as well as symptoms of significant sensory loss associated with diabetes.  
The typically aging older adult does not have to compensate for peripheral neuropathy, but may 
experience some combination of the “normal” changes, such as loss of flexibility and muscle 
strength, impaired balance and postural control, impaired cognition, and the resulting decreased 
functional mobility and independence (Tideikssar, 1994).  Consequences of aging negatively 
impact postural stability, especially for standing tasks that involve visual and spatial 
manipulation, such as backward digit recall while standing on a force platform (Maylor and 
Wing, 1996). The visual, vestibular and somatosensory systems are known as the three influential 
systems involved in postural control and also undergo age-related changes.  Horak places these 
sensory inputs under a larger umbrella of sensory orientation, one of six components that 
comprise the concept of balance (Horak, Wrisley, and Frank, 2009).  Older adults who are 
multiple fallers have been found to have reduced vision, decreased peripheral sensation, slower 
reaction times, and decreased stability compared with non-multiple fallers (Lord, Clark, and 
Webster, 1991, Lord, Lloyd, and Li, 1996).  Sensory impairments and visual disorders were also 
part of a longer list of fall risk factors for older adults, accompanied by history of falls, use of 
assistive devices, muscle weakness, gait and balance impairments, polypharmacy, cognitive 
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impairments, orthostatic hypotension, and environmental hazards (Peel, Brown, and Lane, 2008).   
The degree of impairment in several of these age-related changes is intensified in adults with 
diabetes and some experts recommend diabetic screenings as early as 45 years of age in order to 
detect initial signs of sensory deficits resulting from the disease (ADA, 2002). 
Research Problem and Implications 
It was hypothesized that diabetic homebound adults would exhibit a higher severity of 
fall risk factors that impact the ability to safely maintain postural control than do non-diabetic 
homebound adults, including impaired somatosensation in the feet, increased lower extremity and 
foot pain,  decreased sensory integration, decreased balance, and fear of falling.  These 
differences were anticipated even though both homebound groups are identified as having a high 
fall risk. 
This study was comprised of five research hypotheses: 1) It was hypothesized that the 
incidence and severity of somatosensory changes in the feet, as measured by Semmes-Weinstein 
monofilaments, are significantly different between homebound Type 2 diabetic adults and non-
diabetic homebound adults, 47 years of age and older, because there is a higher incidence of 
sensory loss in the diabetic population;  2) It was hypothesized that incidence of lower leg and 
foot pain as measured by a verbal rating scale (VRS) is greater in diabetic homebound adults, 47 
years of age and older, than non-diabetic homebound adults because diabetics have a higher 
incidence of neuropathic pain; 3) It was hypothesized that deficits in sensory integration as 
measured by the modified Clinical Test for Sensory Integration and Balance (m-CTSIB) are 
greater in homebound diabetic adults, 47 years of age and older , than in non-diabetic homebound 
adults because diabetics have a higher incidence of visual and somatosensory changes than non-
diabetics adults which could negatively impact sensory integration; 4) It was hypothesized that 
balance, as measured by the Dynamic Gait Index, is significantly different between homebound 
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Type 2 diabetic adults ,47 years of age and older, and non-diabetic homebound adults because 
diabetics in general have a higher incidence of falling; and 5) It was hypothesized that fear of 
falling as measured by the Modified Falls Efficacy Scale (MFES) is more significant in 
homebound diabetic adults, 47 years of age and older, than in homebound non-diabetic adults 
because the higher incidence of falls in diabetics is associated with an increase in fear of falling.  
 Earlier detection of these deficits in diabetic adults before they become homebound can 
lead to interventions tailored toward improvement of postural control and prevention of falls.  
These interventions can impact the economic burden of diabetes, which is estimated at $21.5 
million spent annually on diabetic complications (Elftman, 1992). The personal burden of 
diabetes cannot be measured.   
Sensory Changes and Diabetes: Hypothesis I 
 It was hypothesized that the incidence and severity of somatosensory changes in the feet, 
as measured by Semmes-Weinstein monofilaments, are significantly different between 
homebound Type 2 diabetic adults and non-diabetic homebound adults, 47 years of age and older, 
because there is a higher incidence of sensory loss in the diabetic population.  
Postural instability and falls are common complaints of the elderly with or without 
diabetes.  Several studies have linked peripheral nerve dysfunction and the resulting sensory loss 
in the elderly with impaired balance and postural control (Hong, Chia, and Ling, 1997, Katoulis, 
Ebdon-Parry, and Hollis, 1997, Miller, Lui, Perry, Kaiser, and Morley, 1999, Richardson et al, 
1995, Uccioli et al, 1997).  A common cause of sensory dysfunction in older adults includes 
complications resulting from diabetes mellitus (DM), which in 1996 affected 10% of Americans 
aged 65 years or older (CDC [National Diabetes Fact Sheet], 1999). A frequent long-term 
manifestation of DM is the neurologic complication of diabetic neuropathy and the resulting loss 
of sensation and motor control in both upper and lower extremities (Goodman and Boissonnault, 
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1998). Researchers have supported the intuitive relationship between increasing loss of sensation 
due to diabetic peripheral neuropathy and the increasing loss of balance and falls (Ducic, Short, 
and Dillon, 2004).  The diabetes-related complications of reduced peripheral nerve function, renal 
function, and vision contribute to risk of falls in older adults with diabetes (Barclay, 2008).   
 The microvascular pathology accompanying DM is thought by some researchers to follow 
a sequence of: 1) autonomic neuropathy, followed by 2) peripheral sensorimotor (somatomotor) 
neuropathy, followed by 3) local ischemic changes associated with diabetic foot ulcers (Smith, 
2002). This sequence may occur quickly (e.g. when plasma glucose levels are poorly controlled), 
or more slowly, when plasma glucose levels are aggressively maintained by optimization of 
glycemic control. Microvascular pathology (abnormal basement membranes, altered nitric oxide 
levels) due to diabetes is not thought by some researchers to be directly the result of alterations in 
peripheral autonomic function (Smith, 2002). However, abnormal autonomic regulation of the 
microvasculature in diabetes occurs early in the disease process and may contribute to 
abnormalities in tissue perfusion associated with the peripheral microvascular vasculopathy that 
accompanies diabetes.  This sequence of nervous system dysfunction is not well established, but 
could lead to linking autonomic peripheral dysfunction to sensorimotor peripheral dysfunction. 
Autonomic Neuropathy 
The changes in autonomic nervous system function can occur in either the central or 
peripheral systems.  Recent investigators have focused attention on the incidence and progression 
of autonomic dysfunction in both Type 1 and Type 2 diabetes and the potential causal links to 
peripheral somatic neuropathies.  McLeod stated that the autonomic system is affected by most 
conditions that cause peripheral neuropathy and that both sympathetic and parasympathetic 
function should be evaluated when diagnosing conditions such as diabetes (McLeod, 1992).  
McLeod also compared the pathological changes in the peripheral autonomic nervous system to 
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those in the peripheral somatic nerves, suggesting that they are similar and that autonomic 
changes are more likely to occur when there is acute demyelination or damage to small 
myelinated and unmyelinated nerve fibers (McLeod, 1992).    Several other investigators also link 
autonomic and peripheral nervous system changes (Flynn, O’Brien, and Corrall, 1995, Ward, 
1989, Zander, Heinke, and Herfurth, 1997).      
Descriptions of clinical symptoms usually differentiate between autonomic neuropathy 
and peripheral somatic neuropathy.  Manifestations of autonomic neuropathy can include 
variability in heart rate (parasympathetic) and blood pressure (sympathetic) during postural 
changes or physical stress.  A common protocol for testing autonomic function includes three 
tests for parasympathetic control: (cardiac rate response to postural change from lying-to-
standing, deep breathing, and during Valsalva maneuvers); and two sympathetic control 
measures: (orthostatic hypotension as when standing from sitting and blood pressure response to 
the handgrip test).   Autonomic changes are more strongly correlated with people who are 
diagnosed at less than 20 years of age for Type 1 diabetes.  These changes seem to peak at age 
40-49 years of age.  In contrast, the prevalence of peripheral somatic changes increases 
progressively with age (Husstedt, Grotemeyer, and Evers, 1997).  
Evidence supports the coexistence of autonomic and peripheral dysfunction in the same 
person, but the causal relationship between these two diabetic complications is still unclear.  
Okada’s early research results indicate that diabetic somatic neuropathy and 
cardiomyosympathetic neuropathy develop independently in the Type 2 condition (Okada, Ishii, 
and Tamnokuchi, 1995).  However, a subsequent study by Okada correlated diabetic neuropathy 
with blood pressure and glucose control in Type 2 diabetes (Okada, Tamnokuchi, and Ishii, 
1996).  Glucose control also was a significant factor in stabilizing autonomic dysfunction in 
newly diagnosed children with Type 1 diabetes (Adler, Boyko, and Ahroni, 1997), indicating that 
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glucose control may be one contributing factor to the variability in neuropathic complications in 
diabetic people of any age.    Not all researchers agree with this link between glucose control and 
neuropathy, as their results showed no significant improvement in autonomic neuropathy with 
good glycemic control (Gupta, Chittora, and Jain, 1995).           
Conflicting theories exist in the literature regarding the role of central nervous conduction 
deficits, whether they are present in diabetes, and whether they are linked to autonomic and/or 
peripheral sensory changes.  It has been suggested that predisposition to neuropathy may be better 
predicted by central conduction rates versus peripheral conduction pathways in Type 2 diabetes 
(Misra, Mittal, and Jain, 1999).  Another variable associated with the conflicting arguments for a 
direct or indirect relationship between somatic and autonomic changes in the peripheral nervous 
system is the pathogenesis of nerve damage associated with diabetes.  As mentioned previously, 
duration of this disease plays a pivotal role in presence of nervous system changes, the variability 
of which may be explained by the degree of functional versus structural nerve damage and may 
account for the lack of clinical signs despite presence of physiologic dysfunction.   
Peripheral Somatic Neuropathy 
A common form of sensory dysfunction related to diabetes mellitus is that of peripheral 
somatic neuropathies.  This impairment affects people with either Type 1 or Type 2 diabetes and 
typically manifests as tingling and numbness in the hands and feet.  Changes associated with 
peripheral system dysfunction or neuropathy can be divided into functional and structural nerve 
damage.  Functional nerve changes, such as decreased nerve conduction velocity, occur initially 
in the first period of diabetic disease and can be followed by structural changes as the disease 
progresses, leading to many of the clinical manifestations of this condition.  Structural changes 
involve physical degradation of the nerves that inhibit the ability of the nerves to perform 
normally (Ward, 1989).  The presence of peripheral somatic neuropathy in adults with diabetes 
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mellitus of moderate to long duration has been strongly linked to a decrease in postural stability 
due to changes in the somatosensory input necessary for normal balance (Horak, Nashner, and 
Dienr, 1990, Inglis, Horak, and Shupert, 1994).   Few researchers have assessed the presence of 
peripheral somatic changes in early-onset diabetes, which is admittedly difficult to do as many 
adults have the disease several years before actual diagnosis.  Older adults diagnosed with Type 2 
diabetes mellitus may mistake warning signs for this condition with what they consider as typical 
signs of aging.   This confusion of diabetic warning signs with the typical aging process can result 
in delays in assessment and intervention for postural instability and identification of risk for falls.            
  Another type of peripheral neuropathy that can affect postural stability in persons with 
early-onset diabetes involves the autonomic components of the peripheral nervous system.  
Autonomic changes may be linked to somatosensory changes (and indirectly to balance through 
influence on somatosensation) by affecting blood supply to sensory nerves (Smith, 2002).   
Researchers are attempting to understand the potential links between changes in the autonomic 
peripheral nervous system and the peripheral somatic nervous system.  Evidence of autonomic 
and peripheral changes exists for adults with Type 2 diabetes of moderate duration, or 
approximately 5-10 years (Belmin and Valensi, 1996).  Evidence also exists that links peripheral 
somatic system changes and postural instability (Hong, Chia, and Ling, 1997, Simoneau, 
Ulbrecht, and Derr, 1994, Uccioli, Giacomini, and Monticone, 1995). The prevalence of these 
somatosensory changes that result in painful diabetic peripheral neuropathy is estimated at 26.4 % 
for Type II diabetes (Davies et al, 2006). 
Local Ischemic Changes 
Local ischemic changes secondary to diabetes represents a very serious complication of  
the disease.  Loss of normal blood flow to the lower extremities can lead to ulceration, which is 
the most common single precursor to amputation and has been identified as a factor in 85% of 
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lower-extremity amputations (Armstrong et al, 1998).  Diabetics are known to be at high risk for 
lower extremity amputation, which increases their risk for re-amputation of the same extremity, 
amputation of the contralateral leg, an elevated mortality rate in the first 3-5 years after 
amputation, and placement in nursing homes or extended care facilities (Armstrong et al, 1998). 
Amputations are commonly preceded by peripheral neuropathy, ulceration, infection, and 
peripheral vascular disease (Pecoraro, Reiber, and Burgess, 1990).  Ulceration rarely develops 
without some degree of peripheral neuropathy that contributes to a loss of “protective sensation.”  
The majority of diabetic screens used to assess risk for foot ulceration include sensation testing, 
assessment of circulation, and evaluation of skin integrity in an attempt to prevent lower 
extremity amputation.   
Measuring Peripheral Neuropathy      
 An issue regarding measurement methods involves how to measure peripheral somatic 
neuropathy and autonomic peripheral neuropathy.  Vibration threshold using a biothesiometer can 
be used to measure peripheral somatosensory function (Flynn et al, 1995).  This instrument is a 
handheld device with a rubber tactor that vibrates at 100 Hz.  The unit can apply voltage of 
varying degrees that is increased until the subject can perceive a vibration.  It is usually used in 
combination with other assessment tools.  Another reliable means of testing peripheral 
somatosensation incorporates monofilament wire systems of varying thicknesses that are applied 
to the skin.  This system is widely used for identifying diabetic patients at risk for foot ulceration 
(Armstrong et al, 1998).  Another standard method for assessing peripheral somatic neuropathy is 
the analysis of sensory nerve conduction velocity, typically of the tibial, sural, and/or peroneal 
nerves (Belmin and Valensi, 1996).  Standard electrophysiological examinations measure nerve 
conduction velocity, distal latency and potential amplitude for these nerves.  Using this method 
alone to determine the extent of peripheral neuropathy has been criticized by some investigators.   
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Some investigators propose the combination of neurological examination, nerve 
conduction velocity, quantitative sensory tests, and quantitative autonomic tests to estimate 
severity of peripheral neuropathy (Dyck, Melton, and O’Brien, 1997).  This type of system 
considers both impairments and symptoms.  Braune used a neurophysiological approach for early 
detection of diabetic neuropathy (Braune, 1997).  This approach includes a clinical examination, 
nerve conduction velocity of five nerves, evoked sensory and motor action potentials, and 
electromyography of at least four muscles of the lower limbs, and sympathetic skin response for 
hands and feet.  Results of this comprehensive battery suggest that most changes leading to 
pathological values of nerve conduction velocity and heart rate variation measurement take place 
in an early clinical stage, prior to actual clinical signs of diabetic neuropathy.  Researchers 
propose that this battery be used with early-diagnosed diabetics in order to reveal the beginning 
of neuropathic disturbances, with the exception of EMG examinations, which were preferred in 
later stages of the disease (Cheng, Jiang, and Chuang, 1999).  In addition to clinical 
measurements, many investigators stage the degree of peripheral neuropathy for subjects using 
various scales that differentiate between minimal, moderate, and severe degrees of neuropathy 
(Dyck, 1988).  Some of these scales include the Michigan Neuropathy Screening Instrument, the 
Michigan Diabetic Neuropathy Score (Feldman, Stevens, and Thomas, 1994), the San Antonio 
Consensus Statement (Feldman et al, 1994), and the Mayo Clinic protocol (Dyck, Karnes, and 
O’Brien, 1992).  Staging alone or reliance solely on patient self-evaluation has not proven reliable 
enough to accurately measure neuropathies.   Clinical investigators support the use of the 
Semmes-Weinstein monofilaments as the measure of choice for assessing peripheral sensation, 
based on reliability, cost, and practicality (Elftman, 1992).   
 Autonomic peripheral neuropathy has been measured in several different ways and is not as 
widely studied as peripheral somatic neuropathy.  Autonomic changes are known to affect 
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cardiovascular function, so one method of studying these changes includes thermographic 
circulatory patterns following body stressors of warmth or cold.  This method can detect 
vasosympathetic abnormalities that prevent normal changes in skin temperature due to 
microangiopathy (Fushimi, Inoue, and Nishikawa, 1985). Other autonomic function tests of 
cardiosympathetic function include blood pressure response to standing up, the handgrip test for 
blood pressure changes, Valsalva ratio, heart rate response to deep breathing tests, and an 
orthostatic test on a tilt table.  A newer technique using laser Doppler signals looks promising for 
the detection of circulatory abnormalities in peripheral skin.  This technique involves applying a 
body stressor such as heat or cold to the hands or feet and then measuring red blood cell 
movement with a laser as an indicator of normal circulatory responses in the extremities.  This 
type of test appears to be a more direct measure of peripheral autonomic function versus 
measures of central cardiosympathetic function, such as heart rate, in the diabetic population.  
This method is non-invasive, depending on the type of autonomic stressor applied to the 
extremities (Uccioli et al, 1997). 
 Non-invasive laser Doppler fluxmetry has been used as a clinical evaluation of skin 
perfusion. This technique uses a small fiberoptic cable to project coherent light into the skin. The 
electronic circuitry of the instrument then measures the shifts in wavelength of the reflected light 
produced by the Doppler effect of light waves interacting with moving particles (blood cells) 
within the sample area (Smith et al, 1994). With rapid sampling (approximately 10 samples per 
second), the measurements of Doppler- shifted light yield information about the pattern of 
movement of red blood cells within the illumination area. Spectral analysis of these waveforms 
provides quantitative information about specific portions of these waveforms. For example, 
Lindqvist has demonstrated that nervous afferents from the cutaneous thermoreceptors and 
nervous efferents to the skin blood vessels mediate the 0.01 - 0.10 Hz thermo-regulatory 
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oscillations in the forearm skin perfusion waveform (Lindqvist, 1990).  Similar findings have 
been reported by Rossi and by Bernardi using laser Doppler fluxmetry (Bernardi, Rossi, and 
Leuzzi, 1997, Rossi, Ricordi, and Mevio, 1990). This frequency range also is represented in the 
power spectral analysis of cutaneous perfusion in the finger pulp, an area of the skin highly 
invested with arteriovenous anastomoses and predominantly involved with thermoregulation 
(Stansberry, 1996).  
Measuring Peripheral Sensory Loss 
Evaluation of lower extremity sensation is a common component of diabetic risk 
assessment and is central to diagnosing peripheral neuropathy.  Historically, neuropathy was 
identified using subjective symptoms and crude superficial sensory testing.  Quantitative sensory 
testing to determine presence of neuropathy now includes Semmes-Weinstein monofilament 
(SWM) testing, nerve conduction velocity, vibration perception threshold, and/or tactile 
circumferential discriminators (Schox, 2002).  Electrodiagnostic testing such as nerve conduction 
velocity is precise, but is uncomfortable, expensive, and time consuming when compared to other 
more practical approaches to sensory testing.  Biothesiometers measure sensitivity to vibrations 
using voltmeters, but require subjective input from the subject during testing, which negatively 
influences reliability (Schox, 2002).  Tactile circumferential discriminators are new, simple, 
handheld sensory testing devices consisting of a disc with eight protruding rods of increasing 
diameter.  They are highly sensitive, but less specific than vibratory threshold testing and SWM 
(Vileikyte, Hutchings, Hollis, and Boulton, 1997).  Semmes-Weinstein monofilaments are nylon 
filaments of varying diameters that are used to apply tactile pressure to the skin in order to detect 
thresholds of pressure sensation. They have been shown to be reliable when used to test multiple 
sites, but unreliable when used to test a single site (Schox, 2002).  They are inexpensive and can 
be self-administered by diabetics with moderate reliability. Sensitivity and specificity of this 
30 
 
method of sensory testing was reported to be 97% and 83%, respectively (Armstrong et al, 1998).  
One study reported 60.0% sensitivity and 73.8% specificity for diagnosing diabetic peripheral 
neuropathy and recommend their use (Kamei, Yamane, and Nakanishi, 2005).  Most clinicians 
use disposable monofilaments to increase the reliability that can be impacted by continual 
utilization (Yong, Veves, and Smith, 2000).      
Several investigators support the use of SWM as the assessment of choice when 
screening diabetic adults for sensory loss and risk for neuropathy because they are portable, 
inexpensive, painless, easy to administer, acceptable to patients, and provides good predictive 
ability for the risk of foot ulceration and amputation (Mayfield and Sugarman, 2000, Elftman, 
1992).  In a meta-analysis of the use of SWM for sensory testing and neuropathy screening, 
Mayfield found strong support for continued application of this method in diabetic populations 
(Mayfield and Sugarman, 2000).  SWM was identified as one of three important screening tools 
in general medical practice involving diabetics, along with the neuropathy disability score, and 
palpation of foot pulses (Abbott et al, 2002).  SWM, superficial pain sensation, and vibration 
testing were also found to significantly and positively correlate with nerve conduction velocity 
testing in diabetic subjects, with SWM able to differentiate subjects with diabetes with and 
without neuropathy (Olaleye et al, 2001). While this study suggested use of one type of sensory 
testing for diabetic screening purposes, other researchers support the use of a composite 
assessment protocol when determining risk for neuropathy, ulceration, or amputation (Armstrong, 
Lavery, and Harkless, 1996). 
To accurately assess sensation using SWM, the monofilament is applied to the subject’s 
upper arm as a practice trial.  Testing begins with the 4.17-g monofilament indicating normal 
sensation, but never of damaged skin (ulcer site, callus, and scar tissue).  If the subject cannot 
detect sensation with this initial monofilament, then testing is continued with the 5.07 and the 
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6.10 monofilaments.  The monofilament is applied perpendicular to the skin surface with enough 
pressure to bend the monofilament shaft to 45 degrees for about one second, and then removed.  
The subject responds verbally to the size of monofilament that they can feel while blinded to the 
procedure.  Several areas are tested and sensory “maps” are drawn to determine areas of sensory 
loss.  Protocols to screen for diabetic foot complications typically use at least four sites for testing 
the soles of the feet (Diabetic Foot, 2002).  Normative data for sensory thresholds for the foot 
typically use the 4.17g monofilament as the indicator for normal sensation, while the inability to 
feel the 5.07 monofilament represents a 98% loss of sensory ability (Jeng, Michelson, and Mizel, 
1999).  Some authors criticize the accuracy of the sensation levels described in SWM commercial 
kits, stating that these norms were based on small numbers of young subjects, making 
generalization to the older population unadvisable (Jordanova, 1999).  The threshold for normal 
lower extremity sensation of 4.17 monofilament is currently the most widely accepted value 
(Mayfield and Sugarman, 2000).  Areas of the foot that are commonly mapped include the heel, 
mid-arch, first, third and fifth metatarsal heads, and the great toe.  The clinical acceptance, 
repeatability, and sensitivity of SWM testing, along with the ease of application, makes this 
method of sensory assessment the logical choice for identifying sensory changes in newly 
diagnosed diabetic adults and non-diabetic control subjects.  No special training or certifications 
are required in order to safely and reliably assess sensation using SWM commercial kits.    
Sensory Changes and Diabetes: Hypothesis II 
It was hypothesized that incidence of lower leg and foot pain as measured by a verbal 
rating scale (VRS) is greater in diabetic homebound adults, 47 years of age and older, than non-
diabetic homebound adults because diabetics have a higher incidence of neuropathic pain. 
Pain has been identified as a predictor for falls in community-dwelling older adults (Stel, 
Pluijm, and Deeg, 2003).  Neuropathic pain, or peripheral neuropathy that manifests itself as pain, 
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is a symptom commonly experienced by diabetic adults as their loss of peripheral sensation 
progresses from intermittent tingling, burning, and pain, to total numbness.  The etiology of 
neuropathic pain has been explained previously in the section on sensory changes with diabetes 
and typically occurs in people with intermediate duration of DM. As neuropathies progress and 
become painful, a pain assessment is added to the clinical examination, such as the verbal rating 
scale (VRS) or the visual rating scale (VAS), or the less familiar brief pain inventory survey 
(BPI).  The VRS data is preferred by some for pain intensity assessment in a geriatric population 
(Lund, Lundegerg, Kowalski, and Sandberg, 2005), while others prefer the VRS even though the 
two tests correlate highly (0.97 – 0.89) (Clark, Gironda, and Young, 2003).   The prevalence of 
these somatosensory changes that result in painful diabetic peripheral neuropathy is estimated at 
26.4 % for Type II diabetes (Davies et al, 2006).  The high incidence of this diabetic complication 
supports the inclusion of pain surveys in yearly screenings for peripheral neuropathy (Harkless, 
DeLellis, and Carnegie, 2006, Perkins, Olalaye, and Zinman, 2001).   
As mentioned previously, superficial pain sensation, was found to significantly and 
positively correlate with nerve conduction velocity testing in diabetic subjects, assisting in 
differentiating between adults with diabetes with and without neuropathy (Olaleye et al, 2001). 
Assessing lower extremity pain is a purely subjective task and is typically performed using visual 
or verbal analog scales.  The typical scale ranges from 0-10, increasing from no pain (0) to severe 
pain (10).  VAS and VRS methods for pain assessment have been found to be reliable and valid 
(Clark, Vavielle, and Martinez, 2003, Lund et al, 2005).  Inadequate pain control was found to be 
a risk factor for falls in community-dwelling older adults (Nazarko, 2006), and is a required part 
of patient assessment for every homecare visit with Medicare patients.  Lower leg and foot pain 
can result in an altered gait pattern, including decreased stance time on the painful limb, 
decreased gait speed, and decreased walking endurance.  Thus, subjective pain assessment is 
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indicated in assessing overall postural control of diabetic adults due to the complex nature of the 
disease and the dynamic nature of postural control that can be influenced by lower extremity pain. 
Postural Control and Diabetes: Hypothesis III  
It was hypothesized that deficits in sensory integration as measured by the modified 
Clinical Test for Sensory Integration and Balance (m-CTSIB) are greater in homebound diabetic 
adults, 47 years of age and older, than in non-diabetic homebound adults because diabetics have a 
higher incidence of visual and somatosensory changes than non-diabetics adults which could 
negatively impact sensory integration. 
Sensory Integration and Diabetes 
Poor postural stability in older adults has been associated with an increased fall risk 
(Buatois, Gueguen, Gauchard, Benetos, and Perrin, 2006).  Several of the impairments of Type 2 
diabetes have a significant impact on maintenance of postural control and normal sensory 
integration, which contributes to loss of functional mobility.  People with DM who display 
peripheral neuropathy have been found to have decreased plantar flexor muscle peak torque 
compared with control subjects (Mueller, Diamond, and DeLitto, 1989).  Several authors have 
documented decreased ankle joint motion in this population (Andersen and Mogenson, 1997, 
Mueller et al, 1989, Vlassara, 1990).  Gait characteristics such as amount of heel strike and gait 
velocity (Potter, Evans, and Duncan, 1995) and postural stability (increased sway) also are 
impaired (Simoneau et al, 1994).  Impaired peripheral sensory input and vision associated with 
DM also may directly influence maintenance of postural stability and appropriate reactions to 
postural pertubations.  People with Type 2 diabetes may have impaired input from two of these 
systems, especially those with retinopathy and/or peripheral somatic neuropathies (PSN).  People 
with DM and PSN display increasing prevalence of neuropathies over time (Partanen, Niskanen, 
and Lehtinen, 1995) as well as increased postural sway (Boucher, Teasdale, and Courtemanche, 
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1995), shifting in postural strategies (Giamomini, Bruno, and Maonticone, 1996), postural 
instability with head turning tasks (Oppenheim, Kohen-Raz, and Alex, 1999), and eventually can 
be at increased risk for falls.  
 Many older adults are at risk for falls, especially those adults who experience deficits that 
impact vision, somatosensation, and vestibular function (Horak et al, 1990).   Dysfunction of the 
sensory and/or motor systems is a major contributor to an increase in the risk for falls among 
people 65 years of age or older.    Diabetic adults can have deficits that impact vision, sensation, 
and motor control and are at an increased risk for postural instability when compared to non-
diabetic older adults.  Aging diabetic adults in both an urban and a rural setting were found to 
have an increased risk for chronic falling, especially when protective sensation was impaired in 
the lower extremities (Conner-Kerr and Templeton, 2002).  Both urban and rural diabetics in this 
study shared similar risk factors for chronic falling, including positive fall history, daily 
medication intake, number of medical diagnoses, poor performance on the Tinetti Balance tool 
and impaired lower extremity sensation. Diabetic peripheral neuropathy has been directly linked 
to an increased risk for falls (Richardson and Hurvitz, 1995).  Diabetics with peripheral 
neuropathy leading to foot ulceration have also exhibited postural instability as measured by body 
sway (Katoulis et al, 1997).  Peripheral neuropathy was identified as the main factor leading to 
postural instability in diabetics without foot ulceration as measured by body sway and center of 
pressure trace length (Uccioli et al, 1997).  Peripheral neuropathy was indicated as a significant 
factor associated with unstable body sway parameters, along with age, weight, and visual 
impairment secondary to cataracts (Hong et al, 1997).  Most of these studies that linked 
peripheral neuropathy with postural instability involved chronic diabetic adults with obvious loss 
of lower extremity sensation.  Newly diagnosed diabetics were not targeted, as it is assumed that 
the neuropathy process has not begun.   
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Measuring Sensory Integration   
Research has shown that peripheral sensory input from the ankle and foot proprioceptors, 
visual input, and vestibular input are pivotal to normal postural responses. Diabetic adults show 
significant losses in peripheral sensation and are potentially at risk for falls for several reasons.  
Loss of cutaneous sensation has been correlated with impaired postural control and increased risk 
for falling in young adults (Maki and McIlroy, 1999, van Deursen and Simoneau, 1999).  Altering 
sensory feedback from the feet with ice results in changes in muscular activation patterns and gait 
kinematics in healthy adults (Nurse and Nigg, 2001).  Activation of the anterior tibialis was 
highly variable in a group of diabetic adults with impaired sensation in response to an unexpected 
disturbance to upright standing (Simmons and Richardson, 2001).  This variability in muscle 
activation was consistent with greater postural sway and a decrease in stretch reflex response at 
the ankle.   Plantar sensation is also suggested to play an important role in postural control, 
specifically, 1) sensing posterior stability limits during initiation of backward steps, 2) sensing 
and controlling heel-contact and subsequent weight transfer during termination of forward steps, 
and 3) maintaining stability during the prolonged swing phase of lateral crossover steps (Perry, 
McIlroy, and Make, 2000).  Diabetics with bilateral cutaneous sensory deficit in the foot have 
demonstrated an atypical shift from ankle to hip strategy during sensory organization testing, as 
well as compromised foot mechanics (Simmons and Richardson, 1997).  Thus, loss of sensation 
in adult diabetics has significant impact on postural control and normal sensory integration.        
 Three commonly used instruments for measuring sensory integration in older adults in a 
clinical setting that do not have the potential problem of a ceiling effect are the Sensory 
Organization Test (SOT), the modified Clinical Test of Sensory Integration in Balance (m-
CTSIB)(Shumway-Cook and Horak, 1986, Cohen, 1993) and the Sensory-oriented Mobility 
Assessment Instrument (SOMAI)(Tang, Moore, and Woollacott, 1998).  These tests assess a 
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person’s ability to maintain balance under altered sensory conditions, though the SOMAI places 
greater demand on using balance senses during mobility tasks.  The SOT can be performed using 
a force platform to measure root mean square calculations of postural sway to differentiate 
between different types of sensory impairment while the m-CTSIB uses four different sensory 
conditions using the floor and foam to assess sensory integration. The SOMAI score is based on a 
4-point scale for quality of movement during increasingly demanding mobility tasks.  These tasks 
included performing maneuvers in a continuous fashion while adapting to a changing 
environment, walking across uneven floors, walking across cushions placed under carpet, and 
pulling tape off of a wall.  The SOT and SOMAI were not found to correlate during inaccurate 
sensory conditions in community-dwelling older adults and can not be performed easily in the 
home (Tang et al, 1998). The SOT protocol may be beneficial for balance assessment during later 
stages of diabetes when deficits are more prevalent in the visual and somatosensory systems, but 
would not be indicated in newly diagnosed diabetic cohorts who may only exhibit minimal 
deficits in these systems.  The SOT protocol was not found to differentiate between patients 
suffering from whiplash syndrome, Meniere’s disease, and vestibular dysfunction (El-Kahky, 
Kingma, and Dolmans, 2000).    Utilizing the SOT in diabetic subjects is an area in need of 
research.  
The m-CTSIB allows the investigator to note differences in performance between 
conditions that are indicative of visual preference, somatosensory preference, and vestibular 
function, without the use of a force plate or long testing times that homebound older adults could 
not reasonably perform.  The m-CTSIB is more appropriate for homebound adults as it involves 
placing the adult in the standing position of feet together with eyes open and then closed with the 
arms crossed for a target of 30 seconds in each position.  Then the adult stands on a 3-inch piece 
of dense foam in the same positions for 30 seconds each, for a total of four positions.  Poor 
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performance while standing on the floor with eyes open can indicate somatosensory deficits, 
while poor performance during standing on the foam may indicate vestibular hypofunction 
(Cohen, Blatchyly, and Gombash,1993, Whitney, Marchetti, and Schade, 2006). 
Postural Control and Diabetes: Hypothesis IV 
 It was hypothesized that balance, as measured by the Dynamic Gait Index, is significantly 
different between homebound Type 2 diabetic adults, 47 years of age and older, and non-diabetic 
homebound adults because diabetics in general have a higher incidence of falling. 
Measuring Balance 
 When determining the most appropriate method for measuring the variability in postural 
reactions that may result from diabetes, a logical approach may be to decide which aspects of 
balance are influenced the most by loss of normal peripheral sensory input.  Horak and Nashner 
have shown that somatosensory losses result in the increased use of the hip strategy for postural 
correction (Horak et al, 1990).   Thus, one method of measuring postural stability in this 
population would be to use kinematic devices to monitor activation of balance strategies.  Loss of 
peripheral sensory input results in greater body sway, indicating that another method for assessing 
balance could include velocity of body sway and standard deviation.  Uccioli and colleagues 
found a direct correlation between presence of peripheral neuropathy and postural instability as 
measured by the posturographic parameters of trace length, trace surface and body sway (Uccioli 
et al, 1997).  Postural stability has been measured in diabetic adults with peripheral neuropathy 
during various fingertip touch conditions using anterior-posterior and medial-lateral root mean 
square of center of pressure (Dickstein, Shupert, and Horak, 2001).  Again, this type of 
instrumentation is not feasible with a cohort of homebound older adults, leaving the investigator 
with clinical assessments that do not require laboratory methods.  
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Identifying differences in postural stability between diabetics and control groups without 
using a force plate may require a more challenging task than quiet stance, such as head turning 
during walking, (Oppenheim et al, 1999).  The Sharpened Romberg test (feet in tandem with eyes 
open and then closed for 30 seconds) has been used with and without a force plate to assess 
balance.  The Sharpened Romberg was challenging enough to detect vestibular problems in 
cohorts with and without vestibular pathology (Horn, 1997), but has not been used with an adult 
diabetic population.  Semi-tandem stance was used as a condition for determining differences in 
postural control between healthy subjects and those with bilateral vestibular hypofunction with 
eyes open and eyes closed (Riley, Benda, Gill-Body, and Krebs, 1995), but not with diabetics.   
 Several methods have been used to assess postural control and balance reactions in older 
adults.  The most common methods include degree of postural sway during quiet stance, postural 
platform systems that can alter sensory feedback, measuring limits of stability, calculating center 
of pressure and anteroposterior torque exerted on a support surface, the one-leg stance test, and 
numerous functional assessment tools such as the Functional Reach Test (Duncan, Studenski, and 
Chandler,1990) Berg Balance Scale (Berg, Wood-Daphinee, and Williams, 1989), Tinetti Score 
(Tinetti, Williams, and Mayewski, 1986), Dynamic Gait Index (Whitney, Hudak, and Marchetti, 
2000, Whitney, Marchetti, Schade, and Wrisley, 2004) and the Timed Up and Go Test (DiFabio 
and Seay, 1997, Mathias, Nayak, and Issacs, 1986).  
In the laboratory, electromyography has also been useful in determining stereotypical 
muscle response patterns activated during balance tasks, including sequence of muscle firing and 
timing of activation of hip and ankle strategies for balance.  This type of kinematic study 
identified a number of differences in postural stability between young and old adults.  Older 
adults have been found to have more variability in muscle activation during platform testing, 
including slower ankle muscle activation, more cervical muscle activity and less trunk flexor 
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muscle activation, and occasionally reverse the normal distal-to-proximal sequence of muscle 
activation (Hu and Woollacott, 1990, Manchester, Woollacott, and Zederbauer-Hylton, 1989, 
Woollacott, Shumway-Cook, and Nashner, 1986).   Another example of increased variability was 
found in greater joint angle rotation excursions and more variable initial rotation during external 
pertubations to balance (Alexander, Shepard, and Gu, 1992).   This increase in variability is 
compounded by the presence of multiple pathology in older adults, especially those that impact 
the person’s ability to adapt ankle and hip strategies to external forces, such as stroke, 
Parkinson’s disease, or peripheral vascular disease (Black, Shupert, and Horak, 1988).    This 
increased variability exhibited by older adults must be considered when choosing a method of 
testing postural stability.  Unfortunately, the typical homebound older adult does not have access 
to a force plate for this type of sensitive testing for postural control.         
 A clinical approach to assessing postural stability could include the one-leg stance test, 
Functional Reach Test, Berg Balance Scale, Tinetti Scale, Dynamic Gait Index, or Timed Up and 
Go Test.  These more clinical assessments have been proven reliable and valid and most have 
predictive validity for risk for falls for community-dwelling older adults.  While these tools may 
be very appropriate for the clinic, the potential for ceiling effects in those tests using a qualitative 
scale may prove ineffective in identifying early changes in postural control in adults with recently 
diagnosed Type 2 diabetes.  The Dynamic Gait Index has less potential for a ceiling effect based 
on the greater degree of difficulty with head turning activities that the other tests do not include.  
Inclusion of one or more of these functional assessment tools would be indicated in a repeated 
measures study that required follow-up assessment of the effectiveness of an intervention to 
impact postural stability in a more functional environment, though some would argue that specific 
conditions of some of these tests are not always functional. 
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 As mentioned earlier, the Berg Balance Scale is a reliable and valid clinical measure for 
balance and fall risk in older adult populations, but has not been applied specifically in diabetic 
research (Shumway-Cook, Brauer, and Woollacott, 2000).  The Berg test does encompass more 
challenging balance tasks, such as single-limb stance, which could be useful in detecting early 
changes in postural control due to diabetes, but has the limitation of a potential ceiling effect due 
to the 4-point scale used for scoring.  To avoid this potential ceiling effect, the Dynamic Gait 
Index is also a reliable and valid test of balance and fall risk and incorporates the more 
challenging tasks of walking with vertical and horizontal head turns, stepping over objects, and 
negotiating stairs.  It has been validated in community-dwelling older adults (Whitney, Hudak, 
and Marchetti, 2000, Chiu, Fritz, Light, and Velozo, 2006) and found reliable with adults with 
multiple sclerosis (McConvey and Bennett, 2005) and vestibular dysfunction (Whitney, Wrisley, 
and Furman, 2003). 
Fear of Falling: Hypothesis V 
It was hypothesized that fear of falling as measured by the Modified Falls Efficacy Scale 
(MFES) is more significant in homebound diabetic adults, 47 years of age and older, than in 
homebound non-diabetic adults because the higher incidence of falls in diabetics is associated 
with an increase in fear of falling.  
 The psychological consequences of experiencing a fall or fall injury can sometimes be as 
limiting as the physical injuries resulting from falls.  Studies have shown that a fall injury may 
trigger the fear of additional falls (Tinetti, Mendes de Leon, Doucette, and Baker, 1994, Maki, 
Holiday, and Topper, 1991). Fear of falling may lead to increased depressive symptoms and fear 
of institutionalization (Scaf-Clomp, Sanderman, Ormel, and Kempen, 2003).  The fear of another 
fall may lead to decreases in quality of life due to restricting usual activities in hopes of avoiding 
a future fall (Schiller et al, 2007). Fear of falling has been identified as an intrinsic factor 
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associated with recent falls in women with osteoporosis (Arnold, Busch, and Schachter, 2005) 
and older adults transitioning to frailty (Kressig, Wolf, and Sattin, 2001).  Older adults afraid of 
falling reduce their physical activity to prevent outdoor falls (Wijihuizen, de Jong, and Hopman-
Rock, 2007). Fear of falling has also been associated with decreased satisfaction with life, 
increased frailty, depressed mood, recent falls, and decreased mobility (Arfken, Lach, and Birge, 
1994).   Individuals who develop either fear of falling or experience a fall are at risk for 
developing the other, with a resulting spiraling risk of falls, fear of falling, and functional decline 
(Friedman, Munoz, and West, 2002).  Even adults who have never experienced a fall can have a 
higher fear of falling than is justified by their physical condition (Scheffer, Schuurmans, and van 
Dijk, 2008).  An estimated one third of adults who fall develop a fear of falling (Vellas et al, 
1997) and it is suggested that rehabilitation programs address balance confidence as well and the 
physical skills needed for postural control (Tinetti et al, 1994).  One study reports the main risk 
factors for developing a fear of falling are as simple as being female, being older, and 
experiencing at least one fall (Scheffer et al, 2008).     
   Fear of falling, which can impact postural stability, can be assessed using a self-
efficacy survey asking situation-specific questions, such as the Activities-specific Balance 
Confidence (ABC) Scale (Powell and Myers, 1995) or the Modified Falls Efficacy Scale (MFES) 
(Tinetti, Richman, and Powell, 1990, Hill, Schwarz, Kalogeropoulos, and Gibson, 1996).  The 
ABC survey and MFES provide comparable data and are reliable and valid measures of activity-
related fear of falling (Kressig et al, 2001).  The MFES contains questions regarding activities 
that can be performed in the home, while the ABC survey contains some activities that would be 
performed in the community, which a homebound adult would not be able to assess based on 
performance. Older adults with low MFES scores (<75) have been identified as having an 
increased risk for falls (Cumming, Salkeid, and Thomas, 2000).  While some researchers promote 
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the study of fall-related self-efficacy and fear of falling as separate constructs (Legters,  2002, 
Moore and Ellis, 2008), these terms will be used interchangeably fro the purposes of this study.      
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CHAPTER III 
 
METHODS 
 
 
This research investigation involved identification of differences in risk factors for falling 
among homebound diabetic older adults as compared to a control group of non-diabetic 
homebound older adults.  Study methods are described in this chapter.  
Participants 
 This retrospective study involved analysis of data collected over the past four years for 
older adults who have received homecare from Gentiva Health Services in the Triad area of North 
Carolina.  All participants were referred to the Safe Strides balance and fall prevention program.  
The Safe Strides program received referrals from physicians, hospital discharge planners, and 
assisted living facilities for physical therapy intervention to reduce falls and improve balance for 
older homebound adults.  The program was available in the Triad area from September, 2004, to 
the present time.   Approval to conduct this study was obtained from the Gentiva Clinical 
Compliance Board and from the Institutional Review Board at the University of North Carolina at 
Greensboro following an expedited review.   
Study participants were grouped into two cohorts (one diabetic homebound cohort and 
one control cohort of non-diabetic homebound adults).  One cohort consisted of homebound 
diabetic adults between 47 and 98 years of age.  The other group consisted of non-diabetic control 
adults.   Diabetic classification guidelines were followed using the American Diabetes 
Association fasting plasma glucose (FPG) recommendations for glucose level-based 
classifications for Type II diagnosed participants.  An FPG scale rating of less than 110 mg/dL 
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was considered normal, 110-125 mg/dL was the impaired range, and a reading of more than 125 
mg/dL was classified as diabetic (Mayfield,1998).  
The American Diabetes Association recommends that the FPG show elevated plasma 
glucose twice before establishing a diagnosis for diabetes (Halter, 2002).  For the oral glucose 
tolerance test (OGTT), a reading less than 140 mg/dL was considered normal, 140-199 mg/dL 
was in the impaired range, and over 200 mg/dL was classified as diabetes.  The current standard 
of practice was the FPG screening using the ADA ranges listed (Halter, 2002).  Participants were 
recruited from a cohort of homebound older adults seen for health services by Gentiva Home 
Health in the local Piedmont Triad community, specifically in Guilford, Forsyth, Alamance, 
Davie, Davidson, and Surry counties.  All participants were asked to provide informed consent 
using the Gentiva form for Authorization for Release of Information (Appendix A). 
 Participants were tested in their homes and were informed verbally and in writing of the 
goals and risks involved in the physical therapy assessment prior to initiation of treatment and 
data collection (approved consent form by Gentiva Health Services, Appendix B).  The data 
collection was part of the standard physical therapy home health evaluation and did not impact 
the length of treatment, assessment or outcomes of such treatment in any way. Any participant 
could refuse release of information at any time without impact on their delivery of prescribed 
skilled health care.  Participation in the collection of data, or withdrawal from the collection, did 
not affect the participant’s overall treatment in any way.  All participants signed a Consent for 
Treatment form approved by Gentiva and Medicare (Appendix B).   No participants were 
financially compensated for their participation as all participants were Medicare eligible for home 
health services which were covered 100% by Medicare or Medicaid.  Participation in this study 
did not alter the normal delivery, billing, or process of physical therapy services in any way 
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associated with delivery of home health care.  No modifications were made to the testing 
environment.  
Inclusion Criteria  
Participants included men and women 47 years of age and older (to 98 years of age) who 
met the definition of Type II homebound diabetic adult and non-diabetic homebound adult.  
Homebound was defined by the Medicare definition of community activity restricted due to 
taxing effort, safety, or need for supervision when leaving the home.  This is the standard used by 
the home health industry.   Participants with co-morbidities that did not alter the peripheral 
autonomic nervous system, such as hypertension, were included.  Diabetic participants required 
written documentation that they were diagnosed with Type 2 diabetes mellitus, which was 
obtained from the referring physician.  Participants were allowed to wear glasses to correct their 
vision.  Participants in the control cohort were determined to be non-diabetic by their referring 
physician using the accepted medical criteria based on diabetic risk factors: 1) normal glucose 
tolerance testing within the past six months, or 2) no familial history of diabetes, 3) normal blood 
pressure, 4) no evidence of abdominal obesity as defined by waist measurements of more than 40 
inches for men and more than 36 inches for women, and 5) no subjective reports of numbness or 
tingling in the lower extremities, and 6) no history of hyperlipidemia.  If glucose tolerance testing 
had not been previously performed on a participant, but they met fewer than 3 out of the inclusion 
criteria 2-6, they were categorized as having minimal risk for diabetes.  This is the medical 
standard of practice in the United States.       
Exclusion Criteria 
 Participants and controls who were under age 47 or over age 98 were not  included 
because they were generally not homebound at the younger end of the range and had higher 
chance of exclusionary co-morbidities at the upper end of the age range   It was unlikely that 
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female volunteers were pregnant, but they were not included in the study if pregnant because 
pregnancy alters the extremity microcirculation and could alter normal balance strategies 
typically used as a result of the weight gain related to pregnancy.  Persons with connective tissue 
diseases such as scleroderma were not included.  All participants were able to walk with minimal 
assistance, contact guard (minimal manual support from the therapist), supervision, or 
independently with or without an assistive device and were free from wounds or amputations 
involving the lower extremities.  Participants were free from skin ulceration on the feet.  
Participants did not have significant medical problems involving the visual or vestibular systems, 
with the exception of eyeglasses.  Participants were excluded from the control group if they 
displayed more than three of the previously mentioned risk factors for diabetes, specifically 
hypertension, lower extremity cardiovascular disease, foot ulceration, or abdominal obesity. This 
information was obtained using the Gentiva OASIS form required by Medicare for all 
homebound Medicare-eligible adults (Appendix B).  All consent forms, authorization forms, 
medical history, evaluations, and testing results were kept in the participant’s medical record in 
each Gentiva branch.  These records were locked in a file room and were assigned a case number 
by the computerized referral system in each Gentiva office.   
Procedures 
 Each participant completed the Gentiva authorization form, Medicare OASIS form and 
Medicare-specific consent form during the initial home visit following a referral from a licensed 
physician.  A licensed physical therapist employed by Gentiva Health Services interviewed each 
participant to obtain the required information contained in the participant evaluation.  All Gentiva 
therapists were trained to complete the OASIS through an on-line course in Gentiva University 
that requires an 85% passing rate on a comprehensive online exam.  Gentiva University is an on-
line collection of a variety of educational self-paced workbooks designed to assist Gentiva 
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employees in providing home care services.  When the physical therapist completed the OASIS 
they began their assessment, including the study measures, on the initial assessment day or over 
two sessions, depending on the participant’s endurance and tolerance for testing.   The OASIS 
information was available for any caregiver involved in direct care of a participant through the 
medical record housed in a locked file room in the Gentiva branch responsible for the county in 
which the participant lived.   
After completion of the OASIS and physical therapy assessment, an outcome data sheet 
was provided to the principal research investigator by each assessing therapist (Appendix D).  
This form was a standard part of the medical record and contained the data under investigation 
and indication of patient authorization for release of information.  The principal investigator was 
a Gentiva employee and physical therapist in charge of the Safe Strides Balance program in the 
surrounding counties of Guilford, Forsyth, Alamance, Davie, Davidson, and Surry.   
Training of Testers 
The principal investigator has 24 years of experience as a physical therapist with a 
specialization in neurology from the American Physical Therapy Association, as well as 8 years 
of physical therapy instruction at a local university.   The principal investigator personally trained 
every Gentiva physical therapist in the Triad area in performance of the study measures and the 
Safe Strides balance program.  The principal investigator completed a rigorous regional trainer 
program in order to become qualified to train all Triad area physical therapists.  All Gentiva 
therapists also completed a 2-day course on balance assessment and treatment taught by the 
principal investigator, who performed skills competency check-offs on every therapist caring for 
Gentiva patients with balance issues.  All therapists who completed the balance course were 
required to complete eight mandatory lab sessions at their home branch on topics including 
monofilament testing, balance testing, oculomotor testing, etc.  The therapists also practiced these 
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testing skills in monthly labs held in each home branch.  Lab attendance was recorded 
electronically through Gentiva University.  All study participants were evaluated and treated by a 
Safe Strides trained therapist at Gentiva who completed all necessary steps to be Safe Strides 
credentialed by Gentiva. 
Tests and Instrumentation 
   Sensory testing for protective sensation and pain 
 Somatosensory testing of the feet was performed by a physical therapist on all 
participants as part of the testing protocol described by Mueller (Mueller, 1996, Mueller, Minor, 
and Sahrmann, 1994).  Somatosensory testing of both feet was performed using Semmes-
Weinstein monofilaments calibrated at 5.07g (purchased through the Anodyne Company, Tampa, 
FL), which was the size used as the threshold for protective sensation (Mueller, 1996).  Each 
nylon monofilament was calibrated by the manufacturer to deliver its targeted force of 5.07 grams 
when applying sufficient force to produce a 45 degree bend in the shaft, within a 5% standard 
deviation, per manufacturer’s documentation.  The monofilaments were placed in a protected box 
when not in use in order to maintain the integrity of the nylon filament.  After each use the 
monofilament was immediately returned to its protective cover by the therapist.  Bent or kinked 
monofilaments were not used for testing and were replaced.  The monofilament was discarded 
after use with one participant. Both feet were assessed for each participant by testing 5 locations 
on each foot using the same monofilament.  A perfect score was the sum of 5 normal detections 
of the monofilament on each foot, or a score of 10.   
 Each participant was seated comfortably in a chair with a supportive backrest and was 
asked to remove their socks and shoes.  Each foot was tested using the standard method of 
applying a monofilament to each of five areas on the sole of the foot (great toe, first metatarsal 
head, third metatarsal head, fifth metatarsal head, and fourth toe).  The foot was supported during 
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sensory testing by the therapist or by furniture available in each home.   Each application of 
monofilament involved 1-1.5 seconds of pressure at an angle perpendicular to the skin surface 
(enough to result in a 45 degree bend in the filament).  Testing did not occur over callused tissue.  
If skin abnormalities were present the therapist moved to the nearest normal skin adjacent to the 
testing spot.  Testing order was randomized, and each therapist varied the speed of application to 
improve reliability and prevent participants from guessing based on a rhythm of application. Each 
area was tested one time, with an assessment of normal sensibility given using a “yes-no” 
method.  Sensory loss was documented at a site if the monofilament was not sensed correctly.  
Results were recorded on a sensory foot form developed by Gentiva (Appendix E).  Application 
was repeated at a location if the therapist was unsure of a participant’s response.  Only one 
additional repetition was permitted for any location.  The procedure was repeated for the other 
foot, with random order of right versus left foot to be tested first.  Participants were considered at 
risk for peripheral sensory neuropathy if they received 6 (of 10 possible) or fewer correct 
responses to the monofilament applications.  Participants were considered at risk for loss of 
protective sensation if any portion of the foot was insensitive to the monofilament (Mueller, 
1996), which is a conservative criterion for sensory assessment.  Participants at risk were 
informed of this assessment following completion of all testing and were referred to their 
physician for consultation.  A summary of the Semmes-Weinstein scores was provided for the 
physician of any participant at the participant’s request. 
Pain in the feet or lower extremities was assessed by the therapist using a verbal analog 
scale with 0 equating to no pain and 10 equating to the worst pain imaginable.  Participants were 
instructed to rate only the pain, if present, in their feet or lower legs that could be described as 
burning, tingling, or stabbing, which are terms typically used to describe neuropathic pain.  This 
pain score was recorded on the outcome form and on the OASIS assessment. 
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   Postural stability testing for sensory integration 
 Postural stability and sensory integration were assessed using the m-CTSIB test.  This 
test was performed by the physical therapist using a Gentiva digital stopwatch and a 3-inch thick 
piece of dense foam purchased through Gentiva. The high density foam used for the m-CTSIB 
testing was purchased from the AIREX Company who manufactured this product with the 
dimensions of 50 x 41 x 6 cm or 19 x 16 x 2.5 inches (Alcan Airex AG, CH-5643 
Sins/Switzerland). AIREX mats consist of closed-cell foam designed to prevent “bottoming out” 
under rigorous conditions and do not absorb water. The foam was covered by a protective coating 
that allowed removal of dirt or germs using anti-bacterial wipes between testing.  The same type 
of foam was used by each tester and is a standard product used in the physical therapy industry. 
All timing for the m-CTSIB was completed using a Gentiva digital stopwatch supplied to each 
therapist at the Safe Strides training session.  Times were recorded for each position from 0 to 30 
whole seconds.  All times were recorded on the participant outcome form.   
The participant was asked to stand on the floor, with shoes on or off, with their feet as 
close together as possible, while crossing their arms at their chest or waist with their eyes open.  
If a participant could not achieve feet touching due to joint position or soft tissue, the therapist 
recorded the distance between the feet.  Any participant with a distance between feet greater than 
2 inches was excluded from the study, but not from continued therapy.  It the participant could 
not accomplish feet touching due to poor balance, then a score of zero seconds was recorded for 
all positions.  The therapist asked the participant to maintain this position for 30 seconds while 
they timed them using their stopwatch.  Timing stopped if the participant required assistance for 
balance, uncrossed their arms, or exhibited excessive sway that indicated an impending fall.  
They were then asked to repeat this task with their eyes closed.  The third position involved 
standing in the same manner, but on a 3-inch piece of foam with eyes open, then with eyes 
51 
 
closed.  Timing was stopped if the participant uncrossed their arms, lifted their toes off of the 
foam, opened their eyes, or required assistance to prevent loss of balance.  The score in seconds 
for each of four positions was recorded on the outcome form previously mentioned.  A perfect 
score was successful stance in four out of four positions for 30 seconds, or 4/4.  The participants 
were allowed to rest in between positions if necessary, but not for longer than 2-3 minutes.  The 
therapists did not coach the participant in any way during the timing of each position. 
   Fall risk and balance testing 
 Fall risk and balance were tested using the Dynamic Gait Index (DGI).  The DGI is an 8-
item assessment involving gait while performing challenging dynamic activities, including 
walking 20 feet with or without an assistive device, changing gait speed, pivot turning, gait with 
horizontal and vertical head turns, stepping over objects, stepping around objects, and negotiation 
of steps.  Each activity is rated on a 0-3 scale using quality statements printed on the DGI form 
(Appendix F).  A higher score indicated more independence and better balance during the 
required tasks.  Participants were allowed to rest between the 8 DGI activities for at least 1-3 
minutes, depending on their endurance.  The walking path was the space available in each home 
that best matched 20 feet (or as close to 20 feet as possible) of smooth walking surface, which 
could include tile, carpet, hardwood floors, or concrete.  A higher score indicated lesser risk for 
falls.  The highest score was a 24 out of 24 total quality points.  A score of 20/24 or less indicated 
a high fall risk (Whitney et al, 2000).  The DGI score for each participant was recorded on the 
outcome form.   
   Fear of falling assessment 
             Fear of falling (or lack of balance confidence) was measured using the Modified Falls 
Efficacy Scale (Powell and Myers, 1995, Appendix G).  The assessing therapist asked the 
participant to give a subjective assessment of their confidence in completing 14 household tasks 
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without losing their balance.  The possible choices were very confident, fairly confident, and not 
confident at all.  The therapist recorded the participant’s responses.  The total points awarded out 
of 140 possible were recorded on the outcome form.  A score of 60 or fewer indicated a fear of 
falling (poor confidence in balance). 
Primary Data Analysis 
   To test each hypothesis, a univariate analysis of variance (ANOVA), alpha level of .05, 
was utilized to compare diabetic to non-diabetic groups for all fall risk factors.  
Secondary Data Analysis 
Because of the richness of the data set, additional analyses were performed to examine 
possible interaction of gender and age, though these factors were not included in the original 
hypotheses.  To examine the influence of age on differences in mean scores of fall risk factors, 
both cohorts were divided into age categories, defined as 0) 45-54 years, 1) 55- 64 years, 2) 65-74 
years, 3) 75 -84 years, and 4) 85 years and older.  An ANOVA, alpha level .05, was performed to 
identify significant differences by age category and was repeated to examine potential differences 
based on gender.       
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CHAPTER IV 
 
RESULTS 
 
 
 This retrospective study focused on a challenging population of homebound older adults 
identified as appropriate for a physical therapy balance program.  The total cohort was divided   
into two groups, diabetic and non-diabetic, which were compared using five fall risk factors.  The 
risk factors included lower extremity sensation on the plantar surface of the feet, lower extremity 
pain, sensory integration, balance, and fear of falling.  It was hypothesized that the group of 
diabetic older adults would display a greater degree of deficit in each of the five risk factors than 
the non-diabetic group.  The results of this study are described in the following chapter.    
Primary Analysis Results: Difference in Fall Risk Factors 
Participants included in this study totaled 284 homebound older adults (N = 74, diabetics 
and N = 210, non-diabetic adults).  Characteristics and demographic data for both diabetic and 
non-diabetic groups are in Table 1.  The average age in years and standard deviation for both 
cohorts was similar (76.7 yoa + 9.8 years for diabetics and 81.5 yoa +  8.2 years for non-
diabetics).  An independent samples t-test confirmed that there was no significant difference in 
age (t = 4.14, p = .06).  The majority of participants for both cohorts were female and Caucasian, 
though the diabetic group was divided more equally by gender than the non-diabetic group (56.8 
% female and 43.24 % male versus 75.7 % female and 24.3 % male for non-diabetics).  The mean 
scores for both cohorts for each fall risk factor are in Table 2.    
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Table 1. Demographic and Mean Test Data 
 
Characteristic 
 
Diabetic Homebound 
(n=74) 
 
Non-Diabetic Homebound 
(n=210) 
Age (years, mean + Standard 
Deviation (SD) 
76.7 ( 9.8)  
Range = 47 – 95 
81.5 ( 8.2) 
Range = 47 - 98  
Gender (% Female) 56.76 75.71 
Race (% Caucasian) 74.32 85.24 
 
 
Table 2. Data for Fall Risk Factors 
Fall Risk Factor Diabetic Non-Diabetic Skewness Kurtosis 
Pain score (0-10)(SD) 1.89 (3.25) 1.25 (2.62) 1.723 1.448 
Sensory score (0-10)(SD) 6.15 (4.07) 7.59 (3.36) -.919 -.734 
Modified Falls Efficacy Scale 
(0-140)(SD) 
61.94 (28.81) 63.15 (32.65) .257 -.586 
Clinical Test for Sensory 
Integration in Balance 
(CTSIB) 0-120 s (SD) 
39.10 (30.82) 42.72 (32.38) .332 -.960 
Dynamic Gait Index score 
(0-24)(SD) 
9.81 (4.03) 10.01 (4.08) -.049 .170 
 
 
To test each hypothesis, univariate analyses of variance (ANOVA) were performed to 
examine group differences.  All statistics were performed using SPSS version 16.0 with an alpha 
level set at 0.05.  Effect sizes (partial eta squared) also were examined.  Effect sizes of .2 -.3 are 
considered small, .4 - .5 is a medium effect size, and .8-1.0 is a large effect size (Cohen, 1988).      
 
Fall Risk Factor: Sensory Score 
Table 3 contains the results of the ANOVA for sensation. Mean sensory scores differed 
significantly between diabetic and non-diabetic groups (p =.003), but the effect size of .031 
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(partial eta squared) was very low.  Even though the observed power of .85 did reach the 
threshold for ideal power, this effect size was too small to suggest a clinically meaningful 
difference. The diabetic group displayed slightly less sensation in the soles of the feet than the 
non-diabetic group (mean = 6.15 versus 7.59). 
 
Table 3. ANOVA for Sensory Scores 
Dependent Variable: Semmes-Weinstein Score (0-10)   
    
Source 
Type III Sum of 
Squares df 
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Diabetic/No
n-DM 
113.302 1 113.302 8.938 .003 .031 .846
Error 3561.977 281 12.676     
Corrected 
Total 
3675.279 282      
 
 
Fall Risk Factor: Pain 
There was no significant difference between groups in reported pain perceived in the 
lower extremities.  Table 4 contains the results of the ANOVA for pain.  
 
Table 4. ANOVA for Pain 
 
Dependent Variable :Analog Pain         (0-10)    
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Diabetic/nonDM 22.713 1 22.713 2.903 .090 .010 .397
Error 2206.259 282 7.824     
Corrected Total 2228.972 283      
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Fall Risk Factor: Sensory Integration 
 
Mean scores and standard deviations for the modified Clinical Test for Sensory  
Integration in Balance (m-CTSIB) are in Table 2.  These means were not statistically different. 
Results for the ANOVA for the m-CTSIB scores can be found in Table 5.      
 
Table 5. ANOVA for Modified CTSIB 
Dependent Variable :Modified CTSIB    Total Seconds 0-120             
Source 
Type III Sum of 
Squares df 
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Diabetic/Non-
DM 
701.029 1 701.029 .685 .409 .002 .131
Error 283460.068 277 1023.322     
Corrected Total 284161.097 278      
 
Fall Risk Factor: Balance 
Mean scores and standard deviations for the Dynamic Gait Index (DGI) are in Table 2.  
DGI mean scores were not statistically different (p=.712) between groups.   Table 6 contains 
results of the ANOVA for DGI scores.   
    
Table 6. ANOVA for DGI  
Dependent Variable :Balance Tests Dynamic Gait (0-24)   
   
Source 
Type III Sum of 
Squares df 
Mean 
Square F Sig.
Partial Eta 
Squared Observed Powerb
Diabetic/Non-
DM 
2.263 1 2.263 .137 .712 .000 
                        
.066
Error 4626.308 280 16.523     
Corrected Total 4628.571 281      
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Fall Risk Factor: Fear of Falling 
To test differences in fear of falling between groups the Modified Falls Efficacy Scale 
(MFES) scores were analyzed.  Descriptive values for means and standard deviations are in Table 
2.  Table 7 contains results of the ANOVA for MFES.  The mean MFES scores were not 
statistically different between diabetic and non-diabetic groups (p =.789).  Both groups displayed 
means that approached the threshold of 60 points, indicating a fear of falling.           
     
Table 7. ANOVA for MFES 
Dependent Variable: Modified Falls Efficacy Scale                  
0-140 
   
Source 
Type III Sum of 
Squares df 
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Diabetic/Non-DM 72.164 1 72.164 .072 .789 .000 .058
Error 255249.613 254 1004.920     
Corrected Total 255321.777 255      
 
 
Secondary Analysis: Impact of Age and Gender 
 
Impact of Age on Fall Risk Factors  
 
Keeping in mind that age influences activity level and fall incidence in community-
dwelling and institutionalized older adults (Horgas, Wims, and Bataes, 1998), each cohort was 
divided into age categories, defined as 0 = 47-54, 1 = 55-64, 2 = 65-74, 3 = 75-84, and 4 = 85 and 
older.  Table 8 contains frequency information for each age category and diagnostic group.  There 
were no non-diabetic participants in the youngest age group and the cell sizes for the 55-64 year 
olds contained very few participants.  These two youngest age categories were excluded from 
analysis due to the small cell size.   
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Table 8. Frequencies for Age Categories 
Age Category Non-Diabetic Diabetic Total 
0    (47- 54) 0 3 3 
1    (55-64) 7 5 12 
2   (65-74) 33 17 50 
3   (75-84) 90 32 122 
4  (85 plus) 80 17 97 
Totals 210 74 284 
 
A univariate analysis of variance was performed for each of the five fall risk factors to 
identify the impact of increasing age.  No significant differences or interactions were identified 
between the three oldest age categories, with the exception of significant interaction for age, 
diagnosis, and pain (p = .048).  Tables 9 - 13 contain ANOVA results.   
 
Table 9. ANOVA for Sensory Scores by Age and Interaction 
Dependent Variable: Semmes-Weinstein Score             0-10     
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig.
Partial Eta 
Squared 
Observed 
Powerb 
Corrected Model 9465.038a 5 1893.008 .511 .768 .010 .189
Intercept 14232.868 1 14232.868 3.844 .051 .014 .497
Age category 1513.552 2 756.776 .204 .815 .002 .082
Diabetic or Not 1442.733 1 1442.733 .390 .533 .001 .095
Age category * Diabetic 
or Not 
1601.807 2 800.904 .216 .806 .002 .084
Error 973704.724 263 3702.299     
Corrected Total 983169.762 268      
a. R Squared = .010 (Adjusted R Squared = -.009)     
 
 
 
59 
 
Table 10. ANOVA for Pain by Age and Interaction  
Dependent Variable: Analog Pain       Scale               0-10     
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig.
Partial Eta 
Squared 
Observed 
Powerb 
Corrected Model 62.141a 5 12.428 1.727 .129 .032 .592
Intercept 292.525 1 292.525 40.653 .000 .134 1.000
Age category 27.495 2 13.748 1.911 .150 .014 .395
Diabetic or Not 6.568 1 6.568 .913 .340 .003 .159
Age category * Diabetic 
or Not 
44.316 2 22.158 3.079 .048 .023 .591
Error 1892.469 263 7.196     
Corrected Total 1954.610 268      
a. R Squared = .032 (Adjusted R Squared = .013)     
 
 
Table 11. ANOVA for m-CTSIB by Age and Interaction 
Dependent Variable: Modified CTSIB     Total Seconds       0-120    
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig.
Partial Eta 
Squared 
Observed 
Powerb 
Corrected Model 72199.911a 5 14439.982 1.297 .265 .024 .457
Intercept 382067.540 1 382067.540 34.322 .000 .116 1.000
Age category 11964.108 2 5982.054 .537 .585 .004 .138
Diabetic or Not 5325.847 1 5325.847 .478 .490 .002 .106
Age category * 
Diabetic or Not 
19403.913 2 9701.956 .872 .420 .007 .199
Error 2905396.156 261 11131.786     
Corrected Total 2977596.067 266      
a. R Squared = .024 (Adjusted R Squared = .006)     
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Table 12. ANOVA for DGI by Age and Interaction 
Dependent Variable: Balance Tests Dynamic Gait     0-24     
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig.
Partial Eta 
Squared 
Observed 
Powerb 
Corrected Model 4.374a 5 .875 .053 .998 .001 .062
Intercept 17618.750 1 17618.750 1074.303 .000 .805 1.000
Age category 1.499 2 .749 .046 .955 .000 .057
Diabetic or Not .006 1 .006 .000 .985 .000 .050
Age category * 
Diabetic or Not 
2.839 2 1.420 .087 .917 .001 .063
Error 4280.442 261 16.400     
Corrected Total 4284.816 266      
a. R Squared = .001 (Adjusted R Squared = -.018)     
 
 
 
Table 13. ANOVA for MFES by Age and Interaction 
Dependent Variable: Modified Falls Efficacy Scale                  
0-140 
    
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig.
Partial Eta 
Squared 
Observed 
Powerb 
Corrected Model 256220.817a 5 51244.163 .614 .689 .012 .223
Intercept 4934300.002 1 4934300.002 59.120 .000 .184 1.000
Age category 231537.801 2 115768.900 1.387 .252 .010 .297
Diabetic or Not 13593.196 1 13593.196 .163 .687 .001 .069
Age category * 
Diabetic or Not 
46134.701 2 23067.351 .276 .759 .002 .093
Error 2.195E7 263 83462.214     
Corrected Total 2.221E7 268      
a. R Squared = .012 (Adjusted R Squared = -.007)     
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Impact of Gender on Fall Risk Factors 
A univariate analysis of variance was performed for each of the five fall risk factors to 
identify the impact of gender on performance.  This analysis compared cohorts with the following 
cell size: diabetic females (N = 42), non-diabetic females (N = 159), diabetic males (N = 32), and 
non-diabetic males (N = 51).  Tables 14-18 contain ANOVA data for each fall risk factor and 
gender comparisons.  There was no significant impact of gender on any of the five fall risk 
factors, with the exception of pain.  The percentage of women in the diabetic group in this study 
was 56.76%, but was higher in the non-diabetic cohort (75.71 % female).  Despite this difference 
in gender proportion, the only significant interaction identified in fall risk factors was for pain.   
 
Table 14. ANOVA for Sensory Score and Gender 
Dependent Variable: Semmes-Weinstein Score    0-10     
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Corrected Model 160.744a 3 53.581 4.254 .006 .044 .859
Intercept 8964.621 1 8964.621 711.653 .000 .718 1.000
Gender 47.122 1 47.122 3.741 .054 .013 .487
Diabetic or Not 89.361 1 89.361 7.094 .008 .025 .756
Gender * Diabetic or 
Not 
3.766 1 3.766 .299 .585 .001 .085
Error 3514.535 279 12.597     
Corrected Total 3675.279 282      
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Table 15. ANOVA for Pain and Gender 
Dependent Variable : Analog Pain  Scale               0-10    
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Corrected 
Model 
59.280a 3 19.760 2.550 .056 .027 .626
Intercept 421.861 1 421.861 54.441 .000 .163 1.000
Gender 36.553 1 36.553 4.717 .031 .017 .581
Diabetic or Not 24.315 1 24.315 3.138 .078 .011 .423
Gender * 
Diabetic or Not 
5.248 1 5.248 .677 .411 .002 .130
Error 2169.691 280 7.749     
Corrected Total 2228.972 283      
 
Table 16. ANOVA for m-CTSIB and Gender 
Dependent Variable: Modified CTSIB    Total Seconds  0-120                 
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Corrected Model 1992.536a 3 664.179 .647 .585 .007 .185
Intercept 327343.535 1 327343.535 319.027 .000 .537 1.000
Gender 892.159 1 892.159 .869 .352 .003 .153
Diabetic or Not 445.962 1 445.962 .435 .510 .002 .101
Gender * Diabetic or 
Not 
870.319 1 870.319 .848 .358 .003 .151
Error 282168.561 275 1026.067     
Corrected Total 284161.097 278      
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Table 17. ANOVA for DGI and Gender 
Dependent Variable: Balance Tests Dynamic Gait  0-24                 
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Corrected Model 18.779a 3 6.260 .377 .769 .004 .124
Intercept 19312.098 1 19312.098 1164.643 .000 .807 1.000
Gender 1.887 1 1.887 .114 .736 .000 .063
Diabetic or Not .143 1 .143 .009 .926 .000 .051
Gender * Diabetic 
or Not 
16.508 1 16.508 .996 .319 .004 .169
Error 4609.792 278 16.582     
Corrected Total 4628.571 281      
 
Table 18. ANOVA for MFES and Gender 
Dependent Variable: Modified Falls Efficacy Scale  0-140                   
Source 
Type III Sum of 
Squares df
Mean 
Square F Sig. 
Partial Eta 
Squared 
Observed 
Powerb 
Corrected 
Model 
1701.560a 3 567.187 .564 .640 .007 .166
Intercept 707221.283 1 707221.283 702.703 .000 .736 1.000
Gender 1239.430 1 1239.430 1.232 .268 .005 .198
Diabetic or Not 289.212 1 289.212 .287 .592 .001 .083
Gender * 
Diabetic 
 or Not 
42.642 1 42.642 .042 .837 .000 .055
Error 253620.218 252 1006.429     
Corrected Total 255321.777 255      
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Visual Data Patterns 
 
Visual comparison of the means for each risk factor by diagnostic group and age category 
revealed some interesting patterns.  Non-diabetic cohorts are represented by the blue line and 
diabetic cohorts are represented by the green line in each figure.  In Figure 1, the mean diabetic 
sensation score was lower in every age category than the mean score of the non-diabetic age 
groups.  This was the only fall risk factor that showed a consistent pattern in every age group.   
 
 
Figure 1. Line Plot for Mean Sensation Scores  
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The mean lower extremity pain score for diabetics was higher for every age category with 
the exception of the oldest cohort (age 85 – 98 years).  The sensation line plot can be found in 
Figure 2. 
 
Figure 2. Line Plot for Mean Pain Scores 
 
 
 
 
 No interaction was found between age category and diagnosis and the factor of pain.  No 
significant interaction was revealed (p = .052), though the visual analysis of the mean pain scores 
for both groups suggests that non-diabetics reported more pain with increased age with diabetics 
reporting less. 
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 Mean sensory integration scores were lower for all diabetic age categories than that of 
non-diabetics, with the exception of the 65-74 year old group.  The m-CTSIB line plot can be 
found in Figure 3. 
 
Figure 3. Line Plot for m-CTSIB Scores 
 
 
 
 
 Comparison of Dynamic Gait Index scores revealed lower balance scores for every 
diabetic age group, except the 65-74 year olds.  The DGI line plot can be found in Figure 4.         
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Figure 4. Line Plot for Dynamic Gait Index Scores 
 
 
 
 Mean scores for the Modified Falls Efficacy Scale were higher for all diabetic age groups 
when compared to non-diabetic groups, with the exception of the 75-84 years of age cohort.  This 
one diabetic age group reported less fear of falling when compared to same aged non-diabetic 
adults.  Figure 5 contains the line plot for MFES mean scores.        
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Figure 5. Line Plot for MFES Mean Scores 
 
 
 
 
 To visually compare mean values across all variables, the raw data were converted to 
standardized scores.  The non-transformed data were converted to z scores by finding the 
difference between each data point and the mean for that variable and then dividing this 
difference by the standard deviation.  This score identifies how many standard deviation units a 
data point is above or below the mean.  A z score of 1 represents a data point one standard 
deviation above the mean, while -1 represents a value one standard deviation below the mean.  
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This allows a meaningful comparison of the variables with different units of measurement, 
different means, and different standard deviations.  The mean z score for the data points for each 
factor was plotted for comparison.    Figure 6 contains the line plot comparing z score means 
between diagnostic groups.  Pain and lower extremity sensation showed the greatest differences 
in z score means (diabetic pain z score -.06 compared to .17 non-diabetic pain z score; diabetic 
sensation z score mean -.30 compared to .10 non-diabetic z score mean).  Overall, differences for 
all five factors were very small.         
 
Figure 6.  Line Plot for Z Scores for all Variables 
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CHAPTER V 
DISCUSSION 
Summary of Primary Findings 
 After comparison of each fall risk factor for diabetic and non-diabetic adults, only one of 
the proposed hypotheses was supported.  Semmes-Weinstein sensory scores were significantly 
different between diagnostic groups indicating that these diabetic adults experience a greater loss 
of normal sensation in the feet than do non-diabetic adults.  The small effect size limits external 
validity of these results, however.  Secondary analysis showed that sensory scores were lower for 
diabetics at each age compared with non-diabetics.  Other studies exploring why diabetics are 
more likely to fall also identified reduced peripheral nerve function, responsible for sensory and 
motor activity, as a predictor for falls (Barclay and Lie, 2008, Schwartz et al, 2008).  The 
American Diabetes Association, in their 2007 Standards of Medical Care in Diabetes, 
recommended annual screenings for diabetic peripheral neuropathy (DPN) for patients with 
diabetes.  They recommend using a minimum of one clinical test such as monofilament testing, 
pinprick sensation, temperature, or vibration perception (ADA, 2007).  The ADA described the 
association of sensory loss and DPN pain with higher rates of several common geriatric 
syndromes in older adults with diabetes, including polypharmacy, depression, cognitive 
impairment, urinary incontinence, injurious falls, and persistent pain (ADA, 2007).  Though the 
sensory score effect size was too small to be considered clinically meaningful, the results support 
inclusion of monofilament testing in the homebound population because of the severe  
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consequences of the progression of sensory loss if undetected.  This type of sensory screening 
should be part of a comprehensive foot examination designed to recognize common diabetic 
complications that can lead to ulcers or amputations if left untreated.   
  The homebound non-diabetic cohort in the present study may have had a level of sensory 
impairment and pain close to that of the diabetic group due to nerve dysfunction resulting from 
normal aging or other pathology. The loss of normal sensation in diabetic neuropathy predisposes 
joints to repeated trauma and progressive joint destruction and pain, which can be similar to 
complaints of pain due to osteoarthritis or other age-related joint disease. The lack of a clinically 
meaningful difference in sensation or pain in the two diagnostic cohorts can be explained in part 
by the clinical and functional heterogeneity of older adults with diabetes (ADA, 2007).  While 
some older adults acquire diabetes in middle age and face years of co-morbidity and the possible 
transition to frailty, others may experience few complications or have gone undiagnosed for 
years.  Other diabetics enjoy an active life with few co-morbidities.  The extreme variation in 
diabetic medical care also influences the severity of complications and functional disability 
experienced by older adults with this disease.  Variations exist in the medical treatment of critical 
areas in diabetic care, such as glycemic control, blood pressure, and lipid control (ADA, 2007).  
These variations influence results of any study involving homebound older adults with diabetes.    
The factors of sensory integration and balance were not significantly different between 
these diabetic and non-diabetic cohorts.  The presence of co-morbidities in homebound adults, 
such as visual disorders, orthostatic hypotension, or cognitive impairment, may have influenced 
balance and/or sensory integration in all of the participants.  The presence of these co-morbidities 
was not controlled in this study.  Risk factors for falling have been identified as history of falling, 
use of assistive devices for ambulation, muscle weakness, gait and balance impairments, visual 
disorders, polypharmacy, cognitive and sensory impairments, orthostatic hypotension, and 
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environmental hazards (Peel et al, 2008).  The non-diabetic cohort may have experienced at least 
one, if not several, of these risk factors, making it difficult to distinguish between diabetics and 
non-diabetics.   
Though unexpected, the diagnosis of diabetes did not influence fear of falling in our 
homebound cohort, with both diagnostic groups reporting low self-efficacy.  Our results were 
unexpected in light of statistics that indicate increasing incidence of falls in diabetic older adults 
versus non-diabetics (ADA, 2007).  Fear of falling develops for multiple reasons, most commonly 
a history of falls, being an older non-faller, being female, and reporting poorer health and 
functional decline, all common in homebound adults (Legters, 2002).  An increased incidence of 
falls in diabetics would logically result in an increased fear of falling, but our results did not 
substantiate this relationship and we did not record fall history.  A relationship between fear of 
falling and other neurologic diagnosis has been found in conditions such as Parkinson’s disease, 
multiple sclerosis and stroke (Andersson, Kamwendo, and Appelros, 2008, Mak and Pang, 2009, 
Peterson, Cho, von Koch, and Finlayson, 2008).  The reality that older, homebound, non-diabetic 
adults also have an increased fear of falling when compared to homebound diabetic adults may 
help explain our results.  Fear of falling is considered the most common fear of older adults 
(Sharaf and Ibrahim, 2008).  A survey of over 3,400 community-dwelling older Americans 
reported a 22% incidence of fear of falling (Bertera and Bertera, 2008), while others report the 
prevalence as high as 36.2% of all older adults (Boyd and Stevens, 2009).  Fear of falling 
increases after age 65 years (Legters, 2002, Scheffer et al, 2008) and as age approaches 80 years 
and beyond (CDC [fatalities and falls], 2006, Stevens et al, 2008).  Though we did not record fall 
history, the majority of the population included in our study was referred to home health because 
of a fall.  Recurrent falls are more likely to happen with increased age, being female, being 
nonwhite, reporting fair to poor health, and increased number of limitations in personal activities 
73 
 
of daily living and instrumental activities of daily living and co-morbidities (Shumway-Cook, 
Ciol, and Hoffman, 2009).  Older women have been shown to have a 48.4% higher fall rate than 
men (Stalenhoef, Diedriks, and Knottnerus, 2002) and tend to have more serious injuries as a 
result of falling than do men (CDC [fatalities and falls], 2006, Stevens, 2006).  Thus, the 
combination of these factors that can lead to fear of falling in homebound older adults, whether or 
not they are fallers or have diabetes. 
The differences in means for the five fall risk factors, while not statistically significant, 
may be clinically significant when combined to impact health and overall fall risk in an older 
homebound population, whether they are diabetic or whether they are diagnosed with other co-
morbidities.  A diabetic older adult with deficits in multiple areas of balance performance and 
confounding co-morbidities could benefit from earlier interventions designed to address subtle 
changes before they progress to a significant level that renders a person as homebound.  These 
interventions could begin when diabetic adults are first referred for out-patient physical therapy.  
While diabetes is typically not the primary treatment diagnosis for this population, it is a common 
secondary diagnosis (Kirkness, Marcus, and LaStayo, 2008).  A recent study based on primary 
physician records included 52,667 adults and identified 80% of them as having diabetes, pre-
diabetes, or risk factors associated with diabetes, including hypertension, elevated body mass 
index, and elevated triglycerides, resulting in an overall incidence of 13.2 % of diabetes in this 
population (Kirkness et al, 2008). While estimates vary, the prevalence of those diagnosed with 
diabetes is believed by some to have increased 61% from 1990 to 2001, resulting in 6.9 million 
men and 9.8 million women being diagnosed (Mokdad, Ford, and Bowman, 2008).   The 
prevalence of diabetes in the current study was 26.1 % of the total population of 284 participants.  
This is higher than the national averages of diabetes for several age categories (11.2 % for adults 
between 50-59 years of age, 15.1 % for adults between 60-69 years of age, and 15.5 % average 
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for adults over 70 years of age)(Mokdad et al, 2008).  The prevalence of adult-onset diabetes in 
North Carolina has been reported at 7.6 % of the total adult population (Mokdad et al, 2008), 
which is lower than the 26.1 % prevalence found in this study with homebound residents.  While 
diabetes is typically not a primary diagnostic code for adults receiving out-patient therapy, it is 
one of the top ten diagnostic codes for homebound older adults receiving home care in the Triad, 
which helps explain the high incidence in our study (CMS, 2002). As the prevalence of this 
condition increases in the general population, it is crucial for healthcare providers to recognize 
deficits that can impact balance and fall risk, especially in the Medicare population, preferably 
before the diabetic becomes homebound.  
Summary of Secondary Findings 
Further analysis of the data included exploration of the influence of gender and age on 
fall risk.  Comparisons by gender failed to uncover significant effects for any of the five fall risk 
factors for either diagnostic group. The percentage of women in the diabetic group in this study 
was 56.76%, but was higher in the non-diabetic cohort (75.71 % female).  Despite this difference 
in gender proportion, no significant differences in fall risk factors were identified for the two 
groups.  This does not mimic findings in previous research that reported a higher fall rate for 
community dwelling older females than males (Stalenhoef et al, 2002).  Being homebound may 
blur gender differences for fall risk due to co-morbidities, as previously mentioned.     
 Noting that the two youngest age categories contained a small number of participants, 
statistical analyses were repeated using only the three oldest age groups, but no statistical 
significance was identified.  Converting the raw data into standardized z scores allowed 
comparison of all factors on a common scale, using units of standard deviation from the mean.  
Sensation and pain revealed the greatest differences between diagnostic groups, though small, 
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supporting the need for further research to identify the contribution of these factors in assessment 
of overall fall risk for diabetic homebound older adults.   
 Visual analysis of the means for the fall risk factors appeared to indicate interaction of 
age and diagnosis for all factors, excluding somatosensation.  No statistically significant 
interaction was detected for any factor when comparing the three oldest age categories and 
diagnosis. While the sensory means for each diabetic age group revealed poorer somatosensation 
than the non-diabetics, no clear patterns emerged for the other factors.  For pain, the oldest 
diabetic group reported the least amount of pain, while the youngest diabetic group reported the 
highest pain levels of any age group.  The youngest diabetic age category (55-64 years of age) 
contained only 5 participants, but collectively displayed the poorest sensory scores, most pain, 
and lowest DGI and CTSIB scores of any diagnostic group in any age category.  Only the 75-84 
diabetic age group reported more fear of falling than this youngest group.  The small sample size 
for the two youngest diabetic groups makes comparisons difficult.  The 65-74 year old diabetic 
group (n = 17) performed much better than the youngest diabetic group, with the second highest 
scores for any group for the DGI and CTSIB and third highest for the MFES.  The 75-84 year old 
diabetics (n = 32) showed variable performance with the best diabetic mean sensory score, but the 
second worst DGI and MFES scores of any group.  The oldest diabetic group (n = 17), ages 85-98 
years, also lacked a clear pattern with the least pain, second best MFES scores, and second 
poorest CTSIB performance.          
Impact on Therapy Practices 
Diabetic homebound older adults were hypothesized to be at a heightened fall risk when 
compared to the non-diabetic population in this study, but instead, the groups were equally 
impaired for most risk factors.  Accurate identification and testing for fall risk factors for all 
homebound adults, including diabetics, are important steps toward improving the health and 
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decreasing fall risk, but should also be followed by effective treatment.  A recent survey of fall 
prevention knowledge and practice patterns in home health physical therapists found that the 
majority of therapists actively seek to identify risk factors for falls among older patients (Peel et 
al, 2008).  Areas identified that needed enhancements included: understanding the importance of 
certain key risk factors like strength and balance deficits, addressing identified risk factors with 
evidence based interventions, and recognizing when referral to other healthcare professionals is 
warranted (Peel et al, 2008).  Therapists surveyed in this study did not list fear of falling or pain 
as identifiable risk factors for falls, which should be addressed in an effective treatment plan.   
Physical therapists are ideally positioned to provide thorough assessment and effective treatment 
for homebound Medicare population. In 2002, estimates of falls in Medicare beneficiaries were 
estimated at 3.7 million (single fall) to 3.1 million (recurrent falls), with 2.2 million people 
experiencing a medically injurious fall (Shumway-Cook et al, 2009).  The prevalence of injurious 
falls is sure to increase as more of our adult population reaches Medicare age, making 
identification of fall risk factors essential for physical therapists working with older adults.  
Accurate identification of the impaired systems or components of systems may assist therapists in 
deciding how to treat the underlying disorders that lead to falls (Horak et al, 2009).       
Including each risk factor within a multi-factoral approach to determining overall fall risk 
can help drive specific rehabilitation approaches that are more effective at improving overall 
postural control and decreasing falls (Horak et al, 2009).  This type of ‘systems model of motor 
control’ would evaluate interacting components separately to identify differences and 
impairments that impact overall postural control (Horak, Shupert, and Mirka, 1989).  Horak et al 
(2009) proposed that balance is comprised of biomechanical constraints, stability 
limits/verticality, anticipatory postural adjustments, postural responses, sensory orientation, and 
stability in gait.  This conceptual framework that balance function can be divided into separate 
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underlying systems prompted the recent development of the BESTest (Balance Evaluation 
Systems Test, Horak et al, 2009).  This evaluation system contains six sections that correspond 
with to a conceptual framework and test older adults using various tasks contributing to each 
category.  For example, ankle and hip strength are two of the five items that test for 
Biomechanical Constraints (Section 1 of the BESTest).    Early studies using the BESTest show 
excellent interrater reliability and strong agreement with balance confidence (r = .64) (Horak et 
al, 2009), though continued research is necessary to establish validity, sensitivity, and specificity, 
as well as shorten the test.  The BESTest does not include measurement of pain, sensation, or fear 
of falling, but does include the m-CTSIB (Section V: Sensory Orientation) and items from the 
DGI (Section VI: Stability in Gait). BESTest scores did identify poorer performance in different 
subcategories when comparing healthy elderly (n=3) to those with Parkinson’s disease (n=3), 
bilateral vestibular loss (n=3), unilateral vestibular loss (n=2), and peripheral neuropathy (n=1).  
The one participant with peripheral neuropathy in the BESTest study, a common diabetic 
complication, had higher scores overall than adults with Parkinson’s or unilateral vestibular loss.  
This person also performed better than the control group on the m-CTSIB, which demonstrates 
that variability in balance performance in older adults. Dibble recently provided evidence that the 
collective interpretation of multiple clinical balance tests resulted in fewer false-negative results 
when examining fall risk in adults with Parkinson’s disease (Dibble, Christensen, Ballard, and 
Foreman, 2008).  Continued research aimed at identifying specific components of balance and 
fall risk for diabetic adults could be modeled similar to the BESTest and should include, at a 
minimum, the additional factor of sensory scores.  This type of comprehensive assessment could 
be applied in all types of homebound adults, despite diagnosis.  
Further research is needed to determine if pain and fear of falling are part of a “systems 
approach” to fall risk assessment for diabetic older adults.  This type of assessment model could 
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also be helpful to the therapist in identifying the transition from vitality to frailty in homebound 
older adults, who are at risk for losing their independence due to falls, diseases such as diabetes 
or cancer, or disabilities (Hanke and Levi, 2009).    The presence of frailty and co-morbidities that 
exist in homebound older adults could not be controlled in this study.  Some of these co-
morbidities that lead to frailty can also impact the vascular supply to the lower extremities, 
potentially influencing sensory nerve function and impairing sensation.  Examples of these co-
morbidities are cardiovascular disease and atherosclerosis.  Several participants reported no pain 
(0 on a scale of 0-10) and displayed normal sensation (10 on a scale of 0-10), which could 
indicate a lack of sensitivity in the methods used to assess these areas.  Improving the sensitivity 
of the pain examination could help clarify differences between diagnostic groups and is an area 
that home health agencies should explore.  The addition of a pain questionnaire such as in the 
Leeds Assessment of Neuropathic Symptoms and Signs scale (Bennett, Smith, Torrance, and 
Potter, 2005, Cruccu and Truini, 2009) could be a more sensitive tool.  The Leeds assessment is 
designed to identify neuropathic pain without the need for clinical examination and has correctly 
assessed pain in 80% of the cases (Bennett et al, 2005).  The Neuropathic Pain Symptom 
Inventory has been tested with patients reporting diabetic neuropathy and includes descriptive 
terms for neuropathic pain such as burning, electric shocks and pins and needles (Crawford, 
Bouhassira, Wong, and Dukes, 2008).  The Brief Pain Inventory has been described as a 
promising instrument for diabetics with neuropathic pain, dividing the 0-10 scale into mild, 
moderate, and severe categories of pain ratings (Zelman, Dukes, Brandenburg, Bostrom, and 
Gore, 2005, Backonja and Stacey, 2004).     The ADA promotes a multifaceted approach to 
screening for neuropathy, utilizing pinprick testing, temperature and vibration perception, along 
with monofilament testing.  They report a combination of more than one test with >87% 
sensitivity for detecting diabetic peripheral neuropathy (ADA, 2007).   
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Limitations 
Several limitations impact the results of this study, many of which are inherent to 
studying homebound adults. The testing environment may have added variability to the results 
due to differences in the environment, time of day of testing, lighting, distractibility, or support 
surfaces.  Some participants resided in assisted living facilities while others lived in individual 
homes, apartments, or temporary living arrangements with family members.  Age-related 
differences have been found in children and the elderly in the ability to inhibit sensory stimuli by 
cortical structures in the brain, thus making it more difficult to discriminate between visual 
stimuli (Dustman, Emmerson, and Shearer, 1996).  This lack of central control could impact 
balance if an older adult is trying to integrate varying levels of visual, sensory, and auditory 
stimulation.  Homebound older adults must integrate stimulation from a wide range of sources, 
including low lighting, busy wallpaper, uneven walking surfaces, clutter on the floor, noisy traffic 
or phones.  Falls may results from poor integration of these environmental challenges.  While the 
variability in environment represented a challenge to the gathering of data, it was the ideal place 
for therapeutic interventions designed to prevent falls and was considered an acceptable 
limitation.              
 The home health referral process for Gentiva could have contributed to a lack of 
differences between groups.  All participants were identified at the referral process as having 
Medicare coverage for services and as benefiting from physical therapy in the home, specifically 
the Safe Strides balance program.  Homebound older adults identified for Safe Strides had one or 
more health indicators that qualified them for this balance program (history of falls, lower 
extremity weakness, recent hospitalization, etc.).  Inclusion of all participants in this program 
could explain the lack of significant differences between fall risk factors in diabetic and non-
diabetic older adults in the Safe Strides program, as all participants were at a high fall risk based 
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on their referral to home health.  The additional diagnosis of diabetes, in combination with other 
co-morbidities and being homebound, did not differentiate the diabetic from non-diabetic 
potential fallers.      
 Testing reliability may have also contributed to the homogeneity of results for the two 
cohorts.  Several different physical therapists performed testing on participants and though they 
received training from the same investigator, the nature of this retrospective design did not allow 
for reliability testing to be conducted with this group of therapists using these specific 
participants.   
Methods of this study did not control for the length of time since diagnosis with diabetes.  
Some participants may have been newly diagnosed, while others may have been suffering from 
this disease for several years.  This time factor may have significantly impacted sensory and pain 
scores due to the progression of neuropathy, which typically begins after at least 5 years of onset 
of diabetes. The prevalence of undiagnosed diabetes has been reported at 6.2 million cases in the 
United States, or almost 30% of all diabetes cases, in 2005 by the National Health and Nutrition 
Examination Surveys (NHANES, 2005).  This alarmingly high percentage could mean that 
participants included in the non-diabetic group could actually have undiagnosed diabetes, which 
is more common in older adults over the age of 65 years of age.  The presence of undiagnosed 
diabetics in the non-diabetic cohort could help explain the lack of significant difference between 
fall risk factors in these two groups.  Diabetic risk factors were screened for participants in an 
attempt to avoid this type of misclassification.  Other confounding variables, such as body mass 
index, types and number of medications, glucose control in the diabetic group, and psychological 
issues such as depression, were not controlled in this study, thus resulting in a more potentially 
homogeneous cohort.  
81 
 
Future studies involving homebound older adults may find significant differences in fall 
risk factors if the diabetic cohort and non-diabetic cohorts are both referred to general physical 
therapy, versus a specific balance program that already categorizes participants at a higher risk 
for falls.  Including participants with all types of insurance coverage could also be a more 
accurate picture of all homebound older adults, not just those with Medicare Part A.  Testing for 
undiagnosed pre-diabetes prior to data collection could also improve correct grouping of 
participants.  Diabetic participants could also be categorized by length of time since diagnosis (0-
5 years, 6-10 years, 11-15 years, etc.), which could be helpful in tracking the sensory changes that 
occur as this disease progresses and how those changes impact fall risk.   Performing inter-rater 
and intra-rater reliability testing during data gathering in future studies could also be beneficial 
for prospective studies, though difficult for retrospective analysis.  Despite the difficulties that 
accompany research in homebound populations, overcoming these challenges is an important step 
in understanding how to improve and maintain the health of our aging communities.    
Conclusion 
Identifying fall risk factors in homebound diabetic older adults presents a challenge to 
healthcare professionals, including physical therapists.  Of the five risk factors studied, sensation 
on the soles of the feet represents the best differentiator between diabetics and non-diabetics who 
are homebound, supporting the use of monofilament testing in a comprehensive assessment of fall 
risk.  Inclusion of this type of assessment early on in the progression of diabetes may help prevent 
the debilitating complications of ulceration, amputations, and injurious falls.  Further research is 
needed to determine if pain, sensory integration, fear of falling, and balance can be measured with 
enough sensitivity to differentiate diabetics from non-diabetics in a homecare setting.  The 
presence of multiple co-morbidities and advanced age in the homebound population may make it 
difficult to develop sensitive fall risk assessments that are disease-specific.          
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APPENDIX A 
 
AUTHORIZATION FOR RELEASE OF INFORMATION 
 
 
I hereby authorize the use or disclosure of my individually identifiable health information as described 
below.  I understand this authorization is voluntary.  I understand if the organization authorized to receive 
the information is not a health plan or health care provider, the released information may no longer be 
protected by federal privacy regulations. 
 
 
Patient name: __________________________________ Patient number: ________________ 
 
Persons/organizations providing this information:  Gentiva Health Services 
 
Persons/organizations receiving the information:  Gentiva Local, Corporate staff or company agent 
responsible for post-discharge survey completion. 
 
Specific description of information being released and purpose: 
Patient name and medical record number, contact numbers, diagnosis, gender, age for the purpose of 
making post-discharge survey contacts.  The survey purpose is to improve the quality of the Safe Strides 
Program by determining post-discharge clinical outcomes. 
 
The health care provider must complete the following: 
1. Will the health care provider requesting the authorization receive financial or in-kind 
compensation in exchange for using or disclosing the health information described above? 
YES _____ NO      X      
 
The patient or the patient’s representative must read and initial the following statements: 
1. I understand that my health care treatment will not be affected if I do not sign this form. 
Initials: _____ 
2. I understand that I may view and copy the information described on this form at my request, and a 
copy of this form will be provided to me.  Initials:  _____ 
 
The patient or the patient’s representative must read and initial the following statements: 
1. I understand that this authorization will expire two years from the date below.   
Initials:  _____ 
2. I understand that I may revoke this authorization at any time by notifying Gentiva Health Services 
in writing.  The revocation will be effective upon receipt by Gentiva Health Services.   
Initials:  _____ 
 
__________________________________________ ____________________ 
Signature of patient or patient’s representative  Date 
 
Printed name of patient’s representative:  _________________________________________ 
 
Relationship to the patient:  ____________________________________________________ 
 
 
*  YOU MAY REFUSE TO SIGN THIS AUTHORIZATION * 
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CONSENT FOR TREATMENT 
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APPENDIX C 
 
OASIS FORM 
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APPENDIX D 
 
OUTCOME DATA SHEET 
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APPENDIX E 
 
SENSORY FOOT FORM 
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APPENDIX F 
 
DYNAMIC GAIT INDEX FORM 
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APPENDIX G 
 
MODIFIED FALLS EFFICACY SCALE FORM 
 
 
 
